Integra LifeSciences Holdings Corporation (IART)
Princeton, NJ, US
Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.
3 articles
- Integra (IART) Is Attractively Priced Despite Fast-paced Momentum Zacks Investment Research
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.43% | -2.96% | +39.09% | +27.38% | +13.90% | +10.87% | +0.73% | -71.93% | -80.31% | -61.42% | +197.73% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 1 | -1 |
| Hold | 5 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 1 | -1 |
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
12.00
-35.4%
|
| Last Quarter | 1 |
12.00
-35.4%
|
| Last Year | 2 |
13.50
-27.3%
|
| All Time | 15 |
38.60
+107.8%
|
-
Revenue growth Medical - Devices: +11.2%+1.5% Q1'26: +2.4% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%-7,361.2% Q1'26: +81.8% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-29.4% Q1'26: -1.3% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%-29.2% Q1'26: +10.2% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%-17.0% Q1'26: +5.7% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%-0.3% ★ Q1'26: +0.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-6.23× Q1'26: 6.49× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2006 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 4 EPS Ana. |
Dec 2027 6 Rev. Ana. 5 EPS Ana. |
Dec 2028 6 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
419.30M
est: 395.16M (+6.1%)
|
732.07M
est: 665.18M (+10.1%)
|
780.08M
est: 746.68M (+4.5%)
|
830.87M
est: 756.73M (+9.8%)
|
836.21M
est: 844.89M (-1.0%)
|
928.31M
est: 780.25M (+19.0%)
|
882.73M
est: 882.57M (+0.0%)
|
992.08M
est: 994.12M (-0.2%)
|
1.19B
est: 1.17B (+1.2%)
|
1.47B
est: 1.47B (+0.1%)
|
1.52B
est: 1.52B (-0.2%)
|
1.37B
est: 1.37B (0.0%)
|
1.54B
est: 1.54B (+0.1%)
|
1.56B
est: 1.56B (0.0%)
|
1.54B
est: 1.57B (-1.6%)
|
1.61B
est: 1.61B (-0.2%)
|
1.64B
est: 1.63B (+0.3%)
|
1.68B
1.67B – 1.69B
+2.8% YoY
|
1.73B
1.72B – 1.74B
+3.3% YoY
|
1.79B
1.79B – 1.79B
+3.2% YoY
|
| EBITDA |
58.74M
est: 65.61M (-10.5%)
|
139.64M
est: 125.45M (+11.3%)
|
106.31M
est: 102.15M (+4.1%)
|
116.46M
est: 113.68M (+2.4%)
|
40.07M
est: 42.33M (-5.3%)
|
172.24M
est: 122.37M (+40.8%)
|
195.59M
est: 116.39M (+68.1%)
|
231.73M
est: 183.45M (+26.3%)
|
135.23M
est: 130.31M (+3.8%)
|
241.04M
est: 219.52M (+9.8%)
|
223.52M
est: 209.47M (+6.7%)
|
267.93M
est: 256.60M (+4.4%)
|
366.33M
est: 300.57M (+21.9%)
|
384.60M
est: 322.21M (+19.4%)
|
255.96M
est: 178.89M (+43.1%)
|
193.29M
est: 184.22M (+4.9%)
|
-326.20M
est: 186.19M (-275.2%)
|
191.43M
190.29M – 192.58M
+2.8% YoY
|
197.79M
196.65M – 198.93M
+3.3% YoY
|
204.16M
204.16M – 204.16M
+3.2% YoY
|
| EBIT |
58.74M
est: 55.28M (+6.3%)
|
100.47M
est: 88.65M (+13.3%)
|
56.13M
est: 53.23M (+5.5%)
|
74.27M
est: 66.10M (+12.4%)
|
-6.94M
est: -3.24M (-114.3%)
|
67.53M
est: 63.40M (+6.5%)
|
84.21M
est: 59.22M (+42.2%)
|
116.21M
est: 112.13M (+3.6%)
|
46.33M
est: 43.96M (+5.4%)
|
125.34M
est: 104.65M (+19.8%)
|
114.06M
est: 87.18M (+30.8%)
|
148.95M
est: 129.39M (+15.1%)
|
242.66M
est: 169.80M (+42.9%)
|
263.49M
est: 214.49M (+22.8%)
|
132.45M
est: 48.04M (+175.7%)
|
52.40M
est: 49.47M (+5.9%)
|
-477.25M
est: 50.00M (-1,054.6%)
|
51.40M
51.10M – 51.71M
+2.8% YoY
|
53.11M
52.80M – 53.42M
+3.3% YoY
|
54.82M
54.82M – 54.82M
+3.2% YoY
|
| Net Income |
29.41M
est: 27.51M (+6.9%)
|
65.67M
est: 59.02M (+11.3%)
|
27.99M
est: 27.10M (+3.3%)
|
41.20M
est: 37.38M (+10.2%)
|
-16.98M
est: -16.77M (-1.3%)
|
34.00M
est: 32.75M (+3.8%)
|
-3.52M
est: -5.13M (+31.4%)
|
74.56M
est: 70.75M (+5.4%)
|
64.74M
est: 58.37M (+10.9%)
|
60.80M
est: 57.57M (+5.6%)
|
50.20M
est: 45.94M (+9.3%)
|
133.89M
est: 108.10M (+23.9%)
|
169.08M
est: 144.29M (+17.2%)
|
180.55M
est: 161.85M (+11.6%)
|
67.74M
est: 23.20M (+192.0%)
|
-6.94M
est: 188.16M (-103.7%)
|
-516.47M
est: 168.96M (-405.7%)
|
186.56M
182.27M – 190.84M
+10.4% YoY
|
201.52M
195.27M – 207.77M
+8.0% YoY
|
219.74M
182.22M – 257.26M
+9.0% YoY
|
| SGA |
157.71M
est: 148.38M (+6.3%)
|
305.06M
est: 274.18M (+11.3%)
|
358.13M
est: 341.16M (+5.0%)
|
373.11M
est: 334.91M (+11.4%)
|
394.25M
est: 395.97M (-0.4%)
|
445.97M
est: 434.53M (+2.6%)
|
415.76M
est: 422.76M (-1.7%)
|
455.63M
est: 441.68M (+3.2%)
|
624.10M
est: 599.32M (+4.1%)
|
690.75M
est: 652.13M (+5.9%)
|
687.60M
est: 648.00M (+6.1%)
|
594.53M
est: 579.92M (+2.5%)
|
637.45M
est: 543.07M (+17.4%)
|
616.32M
est: 619.02M (-0.4%)
|
656.64M
est: 660.43M (-0.6%)
|
716.98M
est: 680.12M (+5.4%)
|
699.70M
est: 687.37M (+1.8%)
|
706.73M
702.50M – 710.96M
+2.8% YoY
|
730.21M
725.99M – 734.43M
+3.3% YoY
|
753.74M
753.74M – 753.74M
+3.2% YoY
|
| EPS |
0.50
est: 0.64 (-21.9%)
|
1.11
est: 1.17 (-5.1%)
|
0.52
est: 1.31 (-60.3%)
|
0.74
est: 1.27 (-41.7%)
|
-0.30
est: 1.25 (-124.0%)
|
0.52
est: 1.75 (-70.3%)
|
-0.05
est: 1.54 (-103.1%)
|
1.00
est: 1.76 (-43.0%)
|
0.83
est: 1.86 (-55.3%)
|
0.73
est: 2.39 (-69.5%)
|
0.59
est: 2.74 (-78.5%)
|
1.58
est: 2.35 (-32.9%)
|
2.00
est: 3.18 (-37.0%)
|
2.18
est: 3.31 (-34.2%)
|
0.87
est: 0.30 (+187.6%)
|
-0.09
est: 2.45 (-103.7%)
|
-6.73
est: 2.20 (-405.7%)
|
2.44
2.37 – 2.49
+10.6% YoY
|
2.62
2.54 – 2.71
+7.4% YoY
|
2.86
2.37 – 3.35
+9.5% YoY
|
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-06 | Citigroup | Sell | Sell | Maintain |
| 2026-04-15 | Truist Securities | Hold | Hold | Maintain |
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-08 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-06 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-05 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-04 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-01 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-15 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Richard E. Caruso, Ph.D. | 11.05M | 12.87% | 163.7K | 10.89M | 163.7K | — | IN | — | 2020-02-11 | ↗ |
| 2 | Capital Research Global Investors ** | 9.12M | 10.60% | 9.12M | — | 9.12M | — | IA | — | 2020-02-14 | ↗ |
| 3 | Provco Leasing Corporation | 8.74M | 10.32% | — | 8.74M | — | 8.74M | CO | — | 2022-02-14 | ↗ |
| 4 | Tru St Partnership LP | 8.74M | 10.32% | — | 8.74M | — | 8.74M | PN | — | 2022-02-14 | ↗ |
| 5 | (1) BlackRock, Inc. | 6.76M | 8.00% | 6.55M | — | 6.76M | — | HC | Delaware | 2022-02-01 | ↗ |
| 6 | The Vanguard Group - 23-1945930 | 6.66M | 7.86% | — | 34.1K | 6.56M | 98.1K | IA | Pennsylvania | 2022-02-10 | ↗ |
| 7 | Morgan Stanley | 5.68M | 6.80% | — | 5.34M | — | 5.66M | HC, CO | — | 2023-02-09 | ↗ |
| 8 | Wellington Group Holdings LLP | 5.35M | 6.41% | — | 4.75M | — | — | HC | Massachusetts | 2022-10-11 | ↗ |
| 9 | Wellington Investment Advisors Holdings LLP | 5.35M | 6.41% | — | 4.75M | — | — | HC | Massachusetts | 2022-10-11 | ↗ |
| 10 | Wellington Management Group LLP | 5.35M | 6.41% | — | 4.75M | — | — | HC | Massachusetts | 2022-10-11 | ↗ |
| 11 | Wellington Management Company LLP | 5.08M | 6.08% | — | 4.62M | — | — | IA | Massachusetts | 2022-10-11 | ↗ |
| 12 | Fuller & Thaler Asset Management, Inc. | 3.97M | 5.11% | 3.91M | — | 3.97M | — | IA | California | 2024-11-12 | ↗ |
| 13 | EIN #00-0000000 | 3.75M | 4.40% | — | 3.75M | — | 3.75M | IA, HC | — | 2022-02-10 | ↗ |
| 14 | 95-1411037 | 13.00 | 5.50% | 4.30M | — | 4.30M | — | IA | Delaware | 2024-02-09 | ↗ |
Institutional Activity (13F)
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BLACKROCK, INC. | 10.35M +118.5K (+1.2%) | 128.52M -18.1M (-12.3%) | 13.48% +0.104 pp | 0.00% 0.000 pp | USD18.20 -31.8% | 6 qtrs — |
| 2 | RUBRIC CAPITAL MANAGEMENT LP | 7.75M +100.0K (+1.3%) | 96.30M -13.4M (-12.2%) | 10.10% +0.093 pp | 1.15% -0.086 pp | USD18.24 -31.9% | 6 qtrs — |
| 3 | VANGUARD GROUP INC | 7.21M -168.5K (-2.3%) | 89.56M -16.2M (-15.3%) | 9.39% -0.256 pp | 0.00% 0.000 pp | USD35.88 -65.4% | 84 qtrs — |
| 4 | MORGAN STANLEY | 3.85M +24.4K (+0.6%) | 47.81M -7.0M (-12.8%) | 5.01% +0.013 pp | 0.00% -0.001 pp | USD52.71 -76.4% | 51 qtrs — |
| 5 | FULLER & THALER ASSET MANAGEMENT, INC. | 3.64M -278.1K (-7.1%) | 45.16M -10.9M (-19.5%) | 4.74% -0.382 pp | 0.15% -0.038 pp | USD26.14 -52.5% | 27 qtrs — |
| 6 | INVESCO LTD. | 3.52M +31.9K (+0.9%) | 43.75M -6.3M (-12.5%) | 4.59% +0.024 pp | 0.01% -0.001 pp | USD26.87 -53.8% | 57 qtrs — |
| 7 | DIMENSIONAL FUND ADVISORS LP | 3.09M -96.9K (-3.0%) | 38.35M -7.3M (-16.0%) | 4.02% -0.142 pp | 0.01% -0.002 pp | USD31.32 -60.3% | 51 qtrs — |
| 8 | STATE STREET CORP | 2.81M +21.7K (+0.8%) | 34.93M -5.1M (-12.7%) | 3.66% +0.015 pp | 0.00% 0.000 pp | USD39.03 -68.2% | 51 qtrs — |
| 9 | PARADIGM CAPITAL MANAGEMENT INC/NY | 2.66M +135.2K (+5.3%) | 33.10M -3.2M (-8.7%) | 3.47% +0.164 pp | 1.39% -0.178 pp | USD17.09 -27.3% | 6 qtrs — |
| 10 | NEUBERGER BERMAN GROUP LLC | 2.08M +542.0K (+35.3%) | 25.82M +3.9M (+17.6%) | 2.71% +0.699 pp | 0.02% +0.003 pp | USD22.25 -44.2% | 13 qtrs — |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 1.68M +135.7K (+8.8%) | 20.92M -1.3M (-5.7%) | 2.19% +0.169 pp | 0.00% 0.000 pp | USD36.31 -65.8% | 78 qtrs — |
| 12 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.56M +169.9K (+12.2%) | 19.37M -544.7K (-2.7%) | 2.03% +0.215 pp | 0.00% 0.000 pp | USD31.22 -60.2% | 99 qtrs — |
| 13 | GOLDMAN SACHS GROUP INC | 1.44M -96.6K (-6.3%) | 17.83M -4.1M (-18.8%) | 1.87% -0.133 pp | 0.00% -0.001 pp | USD32.56 -61.9% | 73 qtrs — |
| 14 | WELLINGTON MANAGEMENT GROUP LLP | 1.35M +32.2K (+2.4%) | 16.81M -2.1M (-11.2%) | 1.76% +0.035 pp | 0.00% 0.000 pp | USD43.78 -71.6% | 37 qtrs — |
| 15 | J. GOLDMAN & CO LP | 1.24M +293.0K (+30.8%) | 15.45M +1.8M (+13.4%) | 1.62% +0.377 pp | 0.41% +0.064 pp | USD13.30 -6.6% | 6 qtrs — |
| 16 | SYSTEMATIC FINANCIAL MANAGEMENT LP | 1.11M +48.1K (+4.5%) | 13.77M -1.4M (-9.4%) | 1.44% +0.057 pp | 0.32% -0.045 pp | USD22.74 -45.4% | 8 qtrs — |
| 17 | INVENOMIC CAPITAL MANAGEMENT LP | 1.06M +463.7K (+78.3%) | 13.11M +4.6M (+54.5%) | 1.38% +0.601 pp | 0.61% +0.200 pp | USD12.41 +0.1% | 3 qtrs — |
| 18 | QUANTINNO CAPITAL MANAGEMENT LP | 842.1K +601.7K (+250.4%) | 10.46M +7.0M (+203.7%) | 1.10% +0.783 pp | 0.02% +0.012 pp | USD13.69 -9.3% | 12 qtrs — |
| 19 | BANK OF AMERICA CORP /DE/ | 825.1K +201.0K (+32.2%) | 10.25M +1.3M (+14.6%) | 1.08% +0.259 pp | 0.00% +0.000 pp | USD28.56 -56.5% | 52 qtrs — |
| 20 | GLENMEDE TRUST CO NA | 772.9K +772.9K (+100.0%) | 9.60M +9.6M (+100.0%) | 1.01% +1.007 pp | 0.05% +0.046 pp | USD12.42 +0.0% | 1 qtrs NEW |
| 21 | NORTHERN TRUST CORP | 750.0K -64.4K (-7.9%) | 9.31M -2.4M (-20.2%) | 0.98% -0.088 pp | 0.00% 0.000 pp | USD26.21 -52.6% | 51 qtrs — |
| 22 | ALLIANZ ASSET MANAGEMENT GMBH | 650.6K +216.9K (+50.0%) | 8.08M +1.9M (+30.0%) | 0.85% +0.281 pp | 0.01% +0.001 pp | USD15.28 -18.7% | 5 qtrs — |
| 23 | ASSENAGON ASSET MANAGEMENT S.A. | 526.3K +72.0K (+15.8%) | 6.54M +25.8K (+0.4%) | 0.69% +0.092 pp | 0.01% +0.000 pp | USD20.92 -40.6% | 10 qtrs — |
| 24 | JPMORGAN CHASE & CO | 521.1K -30.6K (-5.5%) | 6.47M -1.4M (-18.1%) | 0.68% -0.043 pp | 0.00% 0.000 pp | USD23.08 -46.2% | 45 qtrs — |
| 25 | BANK OF NEW YORK MELLON CORP | 484.4K +90.5K (+23.0%) | 6.02M +371.1K (+6.6%) | 0.63% +0.116 pp | 0.00% +0.000 pp | USD33.49 -62.9% | 66 qtrs — |
| 26 | D. E. SHAW & CO., INC. | 469.6K -155.6K (-24.9%) | 5.83M -3.1M (-34.9%) | 0.61% -0.206 pp | 0.00% -0.002 pp | USD25.81 -51.9% | 49 qtrs — |
| 27 | PRINCIPAL FINANCIAL GROUP INC | 437.9K +35.7K (+8.9%) | 5.44M -324.4K (-5.6%) | 0.57% +0.045 pp | 0.00% 0.000 pp | USD29.30 -57.6% | 81 qtrs — |
| 28 | CANADA PENSION PLAN INVESTMENT BOARD | 434.4K +2.1K (+0.5%) | 5.40M -799.6K (-12.9%) | 0.57% +0.001 pp | 0.00% -0.001 pp | USD13.18 -5.8% | 7 qtrs — |
| 29 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 433.4K -60.6K (-12.3%) | 5.38M -1.7M (-24.0%) | 0.56% -0.081 pp | 0.02% -0.005 pp | USD28.29 -56.1% | 16 qtrs — |
| 30 | ACCESS INVESTMENT MANAGEMENT LLC | 372.5K +— (+0.0%) | 5.34M +— (+0.0%) | 0.49% -0.002 pp | 1.43% +0.000 pp | USD12.27 +1.2% | 3 qtrs — |
| 31 | KOTLER KEVIN | 427.4K +427.4K (+100.0%) | 5.31M +5.3M (+100.0%) | 0.56% +0.557 pp | 1.24% +1.242 pp | USD12.42 +0.0% | 1 qtrs NEW |
| 32 | DEUTSCHE BANK AG\ | 424.8K +66.4K (+18.5%) | 5.28M +140.2K (+2.7%) | 0.55% +0.085 pp | 0.00% +0.000 pp | USD15.53 -20.0% | 50 qtrs — |
| 33 | UBS GROUP AG | 409.0K +277.7K (+211.7%) | 5.08M +3.2M (+170.1%) | 0.53% +0.361 pp | 0.00% +0.001 pp | USD16.03 -22.5% | 45 qtrs — |
| 34 | SG AMERICAS SECURITIES, LLC | 380.2K +380.2K (+100.0%) | 4.72M +4.7M (+100.0%) | 0.50% +0.495 pp | 0.01% +0.006 pp | USD12.42 +0.0% | 3 qtrs — |
| 35 | LEGAL & GENERAL GROUP PLC | 368.9K +126.2K (+52.0%) | 4.58M +1.1M (+31.7%) | 0.48% +0.163 pp | 0.00% +0.000 pp | USD30.61 -59.4% | 46 qtrs — |
| 36 | LEEWARD INVESTMENTS, LLC - MA | 365.0K -1.9K (-0.5%) | 4.53M -724.2K (-13.8%) | 0.48% -0.004 pp | 0.23% -0.039 pp | USD44.42 -72.0% | 16 qtrs — |
| 37 | BNP PARIBAS ARBITRAGE, SNC | 356.8K +57.8K (+19.3%) | 4.43M +147.1K (+3.4%) | 0.46% +0.074 pp | 0.00% 0.000 pp | USD13.82 -10.1% | 51 qtrs — |
| 38 | TWO SIGMA INVESTMENTS, LP | 353.3K -166.1K (-32.0%) | 4.39M -3.1M (-41.0%) | 0.46% -0.219 pp | 0.01% -0.005 pp | USD27.35 -54.6% | 16 qtrs — |
| 39 | RAYMOND JAMES FINANCIAL INC | 267.1K +48.6K (+22.2%) | 3.32M +186.3K (+6.0%) | 0.35% +0.062 pp | 0.00% +0.000 pp | USD15.44 -19.6% | 5 qtrs — |
| 40 | CITADEL ADVISORS LLC | 255.8K +255.8K (+100.0%) | 3.18M +3.2M (+100.0%) | 0.33% +0.333 pp | 0.00% +0.001 pp | USD12.42 +0.0% | 31 qtrs — |
| 41 | PUBLIC SECTOR PENSION INVESTMENT BOARD | 232.2K -29.2K (-11.2%) | 2.88M -861.5K (-23.0%) | 0.30% -0.039 pp | 0.01% -0.004 pp | USD24.21 -48.7% | 7 qtrs — |
| 42 | TREXQUANT INVESTMENT LP | 230.5K +230.5K (+100.0%) | 2.86M +2.9M (+100.0%) | 0.30% +0.300 pp | 0.03% +0.026 pp | USD12.42 +0.0% | 1 qtrs NEW |
| 43 | LSV ASSET MANAGEMENT | 221.3K +— (+0.0%) | 2.75M -422.0K (-13.3%) | 0.29% -0.001 pp | 0.01% -0.001 pp | USD18.73 -33.7% | 6 qtrs — |
| 44 | JANE STREET GROUP, LLC | 200.2K +180.6K (+921.4%) | 2.49M +2.2M (+785.3%) | 0.26% +0.235 pp | 0.00% +0.000 pp | USD12.63 -1.7% | 23 qtrs — |
| 45 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 196.3K +196.3K (+100.0%) | 2.44M +2.4M (+100.0%) | 0.26% +0.256 pp | 0.00% +0.004 pp | USD12.42 +0.0% | 1 qtrs NEW |
| 46 | UBS ASSET MANAGEMENT AMERICAS INC | 196.2K -6.8K (-3.3%) | 2.44M -471.7K (-16.2%) | 0.26% -0.010 pp | 0.00% 0.000 pp | USD32.15 -61.4% | 74 qtrs — |
| 47 | TWO SIGMA ADVISERS, LP | 194.3K -176.7K (-47.6%) | 2.41M -2.9M (-54.6%) | 0.25% -0.232 pp | 0.00% -0.006 pp | USD48.01 -74.1% | 17 qtrs — |
| 48 | RHUMBLINE ADVISERS | 191.9K -9.9K (-4.9%) | 2.38M -508.1K (-17.6%) | 0.25% -0.014 pp | 0.00% 0.000 pp | USD37.77 -67.1% | 51 qtrs — |
| 49 | NUVEEN, LLC | 186.1K -14.7K (-7.3%) | 2.31M -566.3K (-19.7%) | 0.24% -0.020 pp | 0.00% 0.000 pp | USD21.99 -43.5% | 4 qtrs — |
| 50 | TEJARA CAPITAL LTD | 171.8K +51.3K (+42.6%) | 2.13M +407.0K (+23.6%) | 0.22% +0.066 pp | 0.50% -0.399 pp | USD15.24 -18.5% | 4 qtrs — |
| 51 | VICTORY CAPITAL MANAGEMENT INC | 171.3K +99.4K (+138.2%) | 2.13M +1.1M (+106.5%) | 0.22% +0.129 pp | 0.00% +0.001 pp | USD14.40 -13.8% | 26 qtrs — |
| 52 | MILLENNIUM MANAGEMENT LLC | 149.0K -76.0K (-33.8%) | 1.85M -1.4M (-42.6%) | 0.19% -0.100 pp | 0.00% -0.001 pp | USD17.10 -27.4% | 33 qtrs — |
| 53 | BALYASNY ASSET MANAGEMENT L.P. | 136.3K +111.2K (+442.5%) | 1.69M +1.3M (+370.2%) | 0.18% +0.145 pp | 0.00% +0.002 pp | USD12.77 -2.7% | 2 qtrs — |
| 54 | SWISS NATIONAL BANK | 130.7K +2.7K (+2.1%) | 1.62M -210.9K (-11.5%) | 0.17% +0.003 pp | 0.00% 0.000 pp | USD39.35 -68.4% | 51 qtrs — |
| 55 | OLSTEIN CAPITAL MANAGEMENT, L.P. | 123.0K -16.0K (-11.5%) | 1.53M -464.0K (-23.3%) | 0.16% -0.022 pp | 0.31% -0.063 pp | USD29.34 -57.7% | 27 qtrs — |
| 56 | AMERIPRISE FINANCIAL INC | 120.1K -5.9K (-4.7%) | 1.49M -314.2K (-17.4%) | 0.16% -0.008 pp | 0.00% 0.000 pp | USD26.77 -53.6% | 55 qtrs — |
| 57 | AQR CAPITAL MANAGEMENT LLC | 119.5K -11.1K (-8.5%) | 1.48M -315.4K (-17.5%) | 0.16% -0.015 pp | 0.00% 0.000 pp | USD24.91 -50.1% | 27 qtrs — |
| 58 | AMERICAN CENTURY COMPANIES INC | 118.9K +7.3K (+6.6%) | 1.48M -122.3K (-7.6%) | 0.15% +0.009 pp | 0.00% 0.000 pp | USD23.05 -46.1% | 16 qtrs — |
| 59 | IEQ CAPITAL, LLC | 110.9K +99.2K (+843.3%) | 1.38M +1.2M (+717.6%) | 0.14% +0.129 pp | 0.00% +0.004 pp | USD12.62 -1.6% | 2 qtrs — |
| 60 | BARCLAYS PLC | 104.6K -80.3K (-43.4%) | 1.30M -2.1M (-61.3%) | 0.14% -0.106 pp | 0.00% -0.001 pp | USD20.39 -39.1% | 51 qtrs — |
| 61 | HRT FINANCIAL LP | 102.9K +102.9K (+100.0%) | 1.28M +1.3M (+100.0%) | 0.13% +0.134 pp | 0.00% +0.004 pp | USD12.42 +0.0% | 1 qtrs NEW |
| 62 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 101.4K +101.4K (+100.0%) | 1.26M +1.3M (+100.0%) | 0.13% +0.132 pp | 0.01% +0.010 pp | USD12.42 +0.0% | 1 qtrs NEW |
| 63 | ALLIANCEBERNSTEIN L.P. | 99.6K +19.3K (+24.1%) | 1.24M +86.6K (+7.5%) | 0.13% +0.025 pp | 0.00% +0.000 pp | USD48.85 -74.6% | 61 qtrs — |
| 64 | VERITION FUND MANAGEMENT LLC | 96.1K +65.6K (+215.9%) | 1.19M +757.3K (+173.8%) | 0.13% +0.085 pp | 0.00% +0.003 pp | USD12.37 +0.4% | 8 qtrs — |
| 65 | VILLANOVA INVESTMENT MANAGEMENT CO LLC | 82.8K -629.0 (-0.8%) | 1.03M -167.2K (-14.0%) | 0.11% -0.001 pp | 0.73% -0.104 pp | USD16.34 -24.0% | 7 qtrs — |
| 66 | NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 81.2K +— (+0.0%) | 1.01M -155.0K (-13.3%) | 0.11% 0.000 pp | 0.00% 0.000 pp | USD27.44 -54.7% | 51 qtrs — |
| 67 | ENGINEERS GATE MANAGER LP | 79.7K +79.7K (+100.0%) | 989.3K +989.3K (+100.0%) | 0.10% +0.104 pp | 0.01% +0.012 pp | USD12.42 +0.0% | 11 qtrs — |
| 68 | WELLS FARGO & COMPANY/MN | 78.5K +23.5K (+42.7%) | 975.4K +186.6K (+23.7%) | 0.10% +0.030 pp | 0.00% +0.000 pp | USD33.93 -63.4% | 57 qtrs — |
| 69 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 78.4K +— (+0.0%) | 973.4K -149.7K (-13.3%) | 0.10% 0.000 pp | 0.00% 0.000 pp | USD22.42 -44.6% | 5 qtrs — |
| 70 | WALLEYE CAPITAL LLC | 72.4K +72.4K (+100.0%) | 899.1K +899.1K (+100.0%) | 0.09% +0.094 pp | 0.00% +0.003 pp | USD12.42 +0.0% | 1 qtrs NEW |
| 71 | HSBC HOLDINGS PLC | 70.3K +70.3K (+100.0%) | 878.6K +878.6K (+100.0%) | 0.09% +0.092 pp | 0.00% +0.000 pp | USD12.42 +0.0% | 1 qtrs NEW |
| 72 | SUMMIT TRAIL ADVISORS, LLC | 69.3K +18.0K (+34.9%) | 860.9K +124.9K (+17.0%) | 0.09% +0.023 pp | 0.01% +0.005 pp | USD12.31 +0.9% | 3 qtrs — |
| 73 | WINTON GROUP LTD | 68.9K -2.9K (-4.1%) | 855.3K -173.6K (-16.9%) | 0.09% -0.004 pp | 0.03% -0.009 pp | USD21.99 -43.5% | 4 qtrs — |
| 74 | COMERICA BANK | 65.9K +8.4K (+14.6%) | 819.0K -5.3K (-0.6%) | 0.09% +0.011 pp | 0.00% +0.000 pp | USD32.71 -62.0% | 11 qtrs — |
| 75 | SUMMERHAVEN INVESTMENT MANAGEMENT, LLC | 64.8K +— (+0.0%) | 804.4K -123.7K (-13.3%) | 0.08% 0.000 pp | 0.46% -0.084 pp | USD14.33 -13.3% | 2 qtrs — |
| 76 | PRUDENTIAL FINANCIAL INC | 64.3K -4.6K (-6.7%) | 799.1K -189.0K (-19.1%) | 0.08% -0.006 pp | 0.00% 0.000 pp | USD22.76 -45.4% | 85 qtrs — |
| 77 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 63.4K -8.1K (-11.4%) | 787.7K -237.8K (-23.2%) | 0.08% -0.011 pp | 0.00% 0.000 pp | USD32.00 -61.2% | 52 qtrs — |
| 78 | PRICE T ROWE ASSOCIATES INC /MD/ | 63.1K +2.6K (+4.3%) | 784.0K -83.0K (-9.6%) | 0.08% +0.003 pp | 0.00% +0.000 pp | USD31.75 -60.9% | 75 qtrs — |
| 79 | WEDGE CAPITAL MANAGEMENT L L P/NC | 62.7K -2.2K (-3.4%) | 778.4K -151.2K (-16.3%) | 0.08% -0.003 pp | 0.01% -0.002 pp | USD37.98 -67.3% | 10 qtrs — |
| 80 | GREAT WEST LIFE ASSURANCE CO /CAN/ | 59.4K +— (+0.0%) | 737.0K -72.0K (-8.9%) | 0.08% 0.000 pp | 0.00% +0.000 pp | USD44.62 -72.2% | 49 qtrs — |
| 81 | SEI INVESTMENTS CO | 59.2K +32.5K (+121.9%) | 735.2K +352.9K (+92.3%) | 0.08% +0.042 pp | 0.00% +0.000 pp | USD19.57 -36.5% | 45 qtrs — |
| 82 | BRINKER CAPITAL INVESTMENTS, LLC | 58.0K +15.7K (+37.2%) | 720.9K +114.5K (+18.9%) | 0.08% +0.020 pp | 0.01% +0.001 pp | USD18.07 -31.3% | 5 qtrs — |
| 83 | MOORE CAPITAL MANAGEMENT, LP | 53.3K -1.9K (-3.5%) | 662.4K -129.7K (-16.4%) | 0.07% -0.003 pp | 0.01% -0.001 pp | USD12.27 +1.2% | 3 qtrs — |
| 84 | EXCHANGE TRADED CONCEPTS, LLC | 51.0K +13.8K (+37.0%) | 633.1K +99.8K (+18.7%) | 0.07% +0.018 pp | 0.00% +0.000 pp | USD28.49 -56.4% | 25 qtrs — |
| 85 | HEADLANDS TECHNOLOGIES LLC | 50.2K +17.5K (+53.4%) | 623.0K +154.4K (+33.0%) | 0.07% +0.023 pp | 0.05% +0.015 pp | USD15.95 -22.1% | 11 qtrs — |
| 86 | SAPIENCE INVESTMENTS, LLC | 47.4K +7.4K (+18.5%) | 588.5K +15.3K (+2.7%) | 0.06% +0.009 pp | 2.22% -0.025 pp | USD30.35 -59.1% | 28 qtrs — |
| 87 | THRIVENT FINANCIAL FOR LUTHERANS | 46.0K -2.3K (-4.8%) | 572.0K -121.0K (-17.5%) | 0.06% -0.003 pp | 0.00% 0.000 pp | USD30.28 -59.0% | 74 qtrs — |
| 88 | CLEARLINE CAPITAL LP | 43.0K +200.0 (+0.5%) | 534.2K -79.3K (-12.9%) | 0.06% +0.000 pp | 0.03% -0.002 pp | USD25.22 -50.8% | 11 qtrs — |
| 89 | CAMPBELL & CO INVESTMENT ADVISER LLC | 40.3K +40.3K (+100.0%) | 500.5K +500.5K (+100.0%) | 0.05% +0.053 pp | 0.02% +0.024 pp | USD12.42 +0.0% | 19 qtrs — |
| 90 | COUNTERPOINT MUTUAL FUNDS LLC | 40.3K +3.1K (+8.3%) | 500.1K -32.8K (-6.2%) | 0.05% +0.004 pp | 0.04% -0.005 pp | USD12.45 -0.2% | 3 qtrs — |
| 91 | STRS OHIO | 40.1K -8.8K (-18.0%) | 498.0K -202.7K (-28.9%) | 0.05% -0.012 pp | 0.00% -0.001 pp | USD14.58 -14.8% | 7 qtrs — |
| 92 | SOUTH DAKOTA INVESTMENT COUNCIL | 39.5K -3.3K (-7.7%) | 491.0K -122.0K (-19.9%) | 0.05% -0.005 pp | 0.01% -0.003 pp | USD52.56 -76.4% | 30 qtrs — |
| 93 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 39.2K -755.7K (-95.1%) | 487.0K -10.9M (-95.7%) | 0.05% -0.989 pp | 0.01% -0.168 pp | USD21.99 -43.5% | 4 qtrs — |
| 94 | CREATIVE PLANNING | 39.1K +2.7K (+7.5%) | 485.3K -35.5K (-6.8%) | 0.05% +0.003 pp | 0.00% 0.000 pp | USD17.64 -29.6% | 5 qtrs — |
| 95 | STATE OF ALASKA, DEPARTMENT OF REVENUE | 38.6K +393.0 (+1.0%) | 478.0K -69.0K (-12.6%) | 0.05% +0.000 pp | 0.01% -0.001 pp | USD21.37 -41.9% | 37 qtrs — |
| 96 | INSPIRE INVESTING, LLC | 37.5K +6.0K (+19.1%) | 465.5K +14.5K (+3.2%) | 0.05% +0.008 pp | 0.04% -0.002 pp | USD20.99 -40.8% | 18 qtrs — |
| 97 | METLIFE INVESTMENT MANAGEMENT, LLC | 35.8K -5.3K (-12.8%) | 444.4K -143.9K (-24.5%) | 0.05% -0.007 pp | 0.00% -0.001 pp | USD34.16 -63.6% | 33 qtrs — |
| 98 | JANUS HENDERSON GROUP PLC | 33.8K +— (+0.0%) | 418.9K -65.0K (-13.4%) | 0.04% 0.000 pp | 0.00% +0.000 pp | USD57.33 -78.3% | 35 qtrs — |
| 99 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 31.2K -287.0 (-0.9%) | 387.1K -63.6K (-14.1%) | 0.04% -0.001 pp | 0.00% 0.000 pp | USD18.52 -32.9% | 6 qtrs — |
| 100 | LOUISIANA STATE EMPLOYEES RETIREMENT SYSTEM | 30.7K -100.0 (-0.3%) | 381.3K -60.1K (-13.6%) | 0.04% 0.000 pp | 0.01% -0.001 pp | USD31.88 -61.0% | 49 qtrs — |
Insider Activity
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-11 | Veillon-Berteloot Chantal | Officer | F-InKind | D | Common Stock | 5,420 | 9.61 | 52.1K | 22,227 | D | ↗ |
| 2026-03-11 | Singh Harvinder | Officer | A-Award | A | Restricted Stock Units | 60,865 | 0.00 | — | 63,293 | D | ↗ |
| 2026-03-11 | Poul Mojdeh | Director / Officer | A-Award | A | Restricted Stock Units | 343,393 | 0.00 | — | 445,691 | D | ↗ |
| 2026-03-11 | Mosebrook Jeffrey | Officer | A-Award | A | Restricted Stock Units | 15,957 | 0.00 | — | 15,957 | D | ↗ |
| 2026-03-11 | McBreen Michael J. | Officer | F-InKind | D | Common Stock | 7,247 | 9.61 | 69.6K | 60,743 | D | ↗ |
| 2026-03-11 | Knight Lea Daniels | Officer | A-Award | A | Restricted Stock Units | 111,179 | 0.00 | — | 111,179 | D | ↗ |
| 2026-03-11 | Hutchinson Michael Damon | Officer | A-Award | A | Restricted Stock Units | 70,305 | 0.00 | — | 159,911 | D | ↗ |
| 2026-03-11 | DAVIS ROBERT T. JR. | Officer | A-Award | A | Restricted Stock Units | 43,350 | 0.00 | — | 43,350 | D | ↗ |
| 2026-03-10 | Singh Harvinder | Officer | M-Exempt | D | Restricted Stock Units | 1,216 | 0.00 | — | 21,350 | D | ↗ |
| 2026-03-10 | Mosebrook Jeffrey | Officer | F-InKind | D | Common Stock | 341 | 9.55 | 3.3K | 36,259 | D | ↗ |
| 2026-03-10 | McBreen Michael J. | Officer | F-InKind | D | Common Stock | 2,354 | 9.55 | 22.5K | 67,990 | D | ↗ |
| 2026-03-10 | DAVIS ROBERT T. JR. | Officer | F-InKind | D | Common Stock | 687 | 9.55 | 6.6K | 74,874 | D | ↗ |
| 2026-02-02 | Hutchinson Michael Damon | Officer | A-Award | A | Restricted Stock Units | 89,606 | 0.00 | — | 89,606 | D | ↗ |
| 2026-01-27 | Hutchinson Michael Damon | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-01-06 | Poul Mojdeh | Director / Officer | M-Exempt | D | Restricted Stock Units | 848 | 0.00 | — | 102,840 | D | ↗ |
| 2025-11-05 | GRAVES JEFFREY A | Director | P-Purchase | A | Common Stock | 9,000 | 11.35 | 102.2K | 41,086 | D | ↗ |
| 2025-10-12 | Singh Harvinder | Officer | M-Exempt | A | Common Stock | 11,965 | 0.00 | — | 25,217 | D | ↗ |
| 2025-09-01 | Veillon-Berteloot Chantal | Officer | F-InKind | D | Common Stock | 2,139 | 15.13 | 32.4K | 29,059 | D | ↗ |
| 2025-08-14 | ESSIG STUART | Director | J-Other | D | Common Stock | 200,000 | 13.62 | 2.72M | 1,152,236 | D | ↗ |
| 2025-07-03 | Mosebrook Jeffrey | Officer | F-InKind | D | Common Stock | 3,345 | 13.49 | 45.1K | 36,600 | D | ↗ |
| 2025-07-03 | Knight Lea Daniels | Officer | F-InKind | D | Common Stock | 2,561 | 13.49 | 34.5K | 58,578 | D | ↗ |
| 2025-07-01 | Mosebrook Jeffrey | Officer | F-InKind | D | Common Stock | 937 | 13.25 | 12.4K | 39,945 | D | ↗ |
| 2025-05-09 | SCHADE CHRISTIAN S | Director | A-Award | A | Common Stock | 6,939 | 0.00 | — | 70,442 | D | ↗ |
| 2025-05-09 | Lo Renee Wonlai | Director | A-Award | A | Common Stock | 19,592 | 0.00 | — | 35,743 | D | ↗ |
| 2025-05-09 | HILL BARBARA B | Director | A-Award | A | Common Stock | 6,939 | 0.00 | — | 107,261 | D | ↗ |
| 2025-05-09 | GRAVES JEFFREY A | Director | A-Award | A | Common Stock | 19,592 | 0.00 | — | 32,086 | D | ↗ |
| 2025-05-09 | ESSIG STUART | Director / Officer | A-Award | A | Common Stock | 6,939 | 0.00 | — | 647,258 | D | ↗ |
| 2025-05-09 | Clay Shaundra | Director | A-Award | A | Common Stock | 19,592 | 0.00 | — | 41,515 | D | ↗ |
| 2025-05-09 | BRADLEY KEITH | Director | F-InKind | D | Common Stock | 392 | 12.25 | 4.8K | 69,544 | D | ↗ |
| 2025-03-11 | Veillon-Berteloot Chantal | Officer | A-Award | A | Non- Qualified Stock Option (right to buy) | 15,549 | 23.95 | 372.4K | 15,549 | D | ↗ |
| 2025-03-11 | Singh Harvinder | Officer | M-Exempt | D | Restricted Stock Units | 2,356 | 0.00 | — | 34,531 | D | ↗ |
| 2025-03-11 | Schwartz Eric | Officer | F-InKind | D | Common Stock | 1,180 | 23.95 | 28.3K | 56,020 | D | ↗ |
| 2025-03-11 | Mosebrook Jeffrey | Officer | F-InKind | D | Common Stock | 309 | 23.95 | 7.4K | 35,368 | D | ↗ |
| 2025-03-11 | McBreen Michael J. | Officer | A-Award | A | Non- Qualified Stock Option (right to buy) | 39,132 | 23.95 | 937.2K | 39,132 | D | ↗ |
| 2025-03-11 | Knight Lea Daniels | Officer | F-InKind | D | Common Stock | 1,655 | 23.95 | 39.6K | 40,280 | D | ↗ |
| 2025-03-11 | DAVIS ROBERT T. JR. | Officer | A-Award | A | Non- Qualified Stock Option (right to buy) | 26,310 | 23.95 | 630.1K | 26,310 | D | ↗ |
| 2025-03-10 | Singh Harvinder | Officer | M-Exempt | D | Restricted Stock Units | 1,180 | 0.00 | — | 36,887 | D | ↗ |
| 2025-03-10 | Schwartz Eric | Officer | F-InKind | D | Common Stock | 773 | 22.61 | 17.5K | 58,738 | D | ↗ |
| 2025-03-10 | Mosebrook Jeffrey | Officer | F-InKind | D | Common Stock | 166 | 22.61 | 3.8K | 35,811 | D | ↗ |
| 2025-03-10 | McBreen Michael J. | Officer | F-InKind | D | Common Stock | 1,056 | 22.61 | 23.9K | 53,897 | D | ↗ |
| 2025-03-10 | DAVIS ROBERT T. JR. | Officer | F-InKind | D | Common Stock | 592 | 22.61 | 13.4K | 64,515 | D | ↗ |
| 2025-01-06 | Poul Mojdeh | Director / Officer | A-Award | A | Non- Qualified Stock Option (right to buy) | 217,961 | 21.70 | 4.73M | 217,961 | D | ↗ |
| 2024-12-03 | Schwartz Eric | Officer | S-Sale | D | Common Stock | 4,070 | 24.60 | 100.1K | 59,511 | D | ↗ |
| 2024-12-02 | McBreen Michael J. | Officer | S-Sale | D | Common Stock | 1,700 | 24.16 | 41.1K | 56,182 | D | ↗ |
| 2024-11-01 | De Witte Jan | Director / Officer | M-Exempt | A | Common Stock | 9,814 | 0.00 | — | 28,164 | D | ↗ |
| 2024-09-01 | Veillon-Berteloot Chantal | Officer | F-InKind | D | Common Stock | 1,412 | 20.34 | 28.7K | 24,379 | — | ↗ |
| 2024-08-19 | Mosebrook Jeffrey | Officer | S-Sale | D | Common Stock | 1,191 | 21.58 | 25.7K | 36,088 | — | ↗ |
| 2024-07-03 | Knight Lea Daniels | Officer | F-InKind | D | Common Stock | 2,561 | 28.73 | 73.6K | 41,935 | — | ↗ |
| 2024-07-01 | Mosebrook Jeffrey | Officer | A-Award | A | Common Stock | 10,356 | 0.00 | — | 37,279 | — | ↗ |
| 2024-05-23 | ESSIG STUART | Director / Officer | P-Purchase | A | Common Stock | 52,641 | 28.49 | 1.50M | 487,922 | — | ↗ |
| 2024-05-21 | HILL BARBARA B | Director | P-Purchase | A | Common Stock | 36,350 | 27.40 | 995.8K | 36,350 | — | ↗ |
| 2024-05-12 | BRADLEY KEITH | Director | F-InKind | D | Common Stock | 37 | 25.99 | 961.63 | 69,936 | — | ↗ |
| 2024-05-09 | SCHADE CHRISTIAN S | Director | A-Award | A | Common Stock | 8,696 | 0.00 | — | 63,503 | — | ↗ |
| 2024-05-09 | Murphy Raymond G. | Director | A-Award | A | Common Stock | 8,696 | 0.00 | — | 54,007 | — | ↗ |
| 2024-05-09 | Lo Renee Wonlai | Director | A-Award | A | Common Stock | 8,696 | 0.00 | — | 16,151 | — | ↗ |
| 2024-05-09 | HILL BARBARA B | Director | A-Award | A | Common Stock | 3,163 | 0.00 | — | 91,626 | — | ↗ |
| 2024-05-09 | GRAVES JEFFREY A | Director | A-Award | A | Common Stock | 1,582 | 0.00 | — | 3,798 | — | ↗ |
| 2024-05-09 | ESSIG STUART | Director / Officer | A-Award | A | Common Stock | 10,672 | 0.00 | — | 935,281 | — | ↗ |
| 2024-05-09 | Clay Shaundra | Director | A-Award | A | Common Stock | 8,696 | 0.00 | — | 21,923 | — | ↗ |
| 2024-05-09 | BRADLEY KEITH | Director | A-Award | A | Common Stock | 8,696 | 0.00 | — | 70,175 | — | ↗ |
| 2024-03-12 | Schwartz Eric | Officer | F-InKind | D | Common Stock | 348 | 35.88 | 12.5K | 63,581 | — | ↗ |
| 2024-03-12 | Mosebrook Jeffrey | Officer | F-InKind | D | Common Stock | 223 | 35.88 | 8.0K | 27,047 | — | ↗ |
| 2024-03-12 | McBreen Michael J. | Officer | F-InKind | D | Common Stock | 440 | 35.88 | 15.8K | 57,882 | — | ↗ |
| 2024-03-12 | DAVIS ROBERT T. JR. | Officer | F-InKind | D | Common Stock | 443 | 35.88 | 15.9K | 66,688 | — | ↗ |
| 2024-03-11 | Veillon-Berteloot Chantal | Officer | A-Award | A | Non- Qualified Stock Option (right to buy) | 8,027 | 36.22 | 290.7K | 8,027 | — | ↗ |
| 2024-03-11 | Singh Harvinder | Officer | A-Award | A | Restricted Stock Units | 7,140 | 0.00 | — | 21,501 | — | ↗ |
| 2024-03-11 | Schwartz Eric | Officer | F-InKind | D | Common Stock | 1,371 | 36.22 | 49.7K | 48,991 | — | ↗ |
| 2024-03-11 | Mosebrook Jeffrey | Officer | F-InKind | D | Common Stock | 130 | 36.22 | 4.7K | 23,860 | — | ↗ |
| 2024-03-11 | McBreen Michael J. | Officer | A-Award | A | Common Stock | 8,283 | 0.00 | — | 59,894 | — | ↗ |
| 2024-03-11 | Knight Lea Daniels | Officer | A-Award | A | Non- Qualified Stock Option (right to buy) | 27,308 | 36.22 | 989.1K | 27,308 | — | ↗ |
| 2024-03-11 | De Witte Jan | Director / Officer | A-Award | A | Restricted Stock Units | 41,414 | 0.00 | — | 130,485 | — | ↗ |
| 2024-03-11 | DAVIS ROBERT T. JR. | Officer | A-Award | A | Common Stock | 13,805 | 0.00 | — | 67,131 | — | ↗ |
| 2024-03-10 | Singh Harvinder | Officer | M-Exempt | A | Common Stock | 1,179 | 0.00 | — | 1,179 | — | ↗ |
| 2024-03-10 | Schwartz Eric | Officer | F-InKind | D | Common Stock | 799 | 36.73 | 29.3K | 50,362 | — | ↗ |
| 2024-03-10 | Mosebrook Jeffrey | Officer | F-InKind | D | Common Stock | 166 | 36.73 | 6.1K | 23,990 | — | ↗ |
| 2024-03-10 | McBreen Michael J. | Officer | F-InKind | D | Common Stock | 1,198 | 36.73 | 44.0K | 43,313 | — | ↗ |
| 2024-03-10 | De Witte Jan | Director / Officer | F-InKind | D | Common Stock | 346 | 36.73 | 12.7K | 18,350 | — | ↗ |
| 2024-03-10 | DAVIS ROBERT T. JR. | Officer | F-InKind | D | Common Stock | 635 | 36.73 | 23.3K | 49,258 | — | ↗ |
| 2024-03-06 | DAVIS ROBERT T. JR. | Officer | M-Exempt | A | Common Stock | 8,736 | 32.59 | 284.7K | 58,241 | — | ↗ |
| 2024-02-20 | Schwartz Eric | Officer | A-Award | A | Common Stock | 2,564 | 0.00 | — | 51,161 | — | ↗ |
| 2024-02-20 | Mosebrook Jeffrey | Officer | A-Award | A | Common Stock | 808 | 0.00 | — | 24,266 | — | ↗ |
| 2024-02-20 | McBreen Michael J. | Officer | A-Award | A | Common Stock | 3,516 | 0.00 | — | 45,968 | — | ↗ |
| 2024-02-20 | DAVIS ROBERT T. JR. | Officer | A-Award | A | Common Stock | 3,721 | 0.00 | — | 49,505 | — | ↗ |
| 2024-01-18 | De Witte Jan | Director / Officer | M-Exempt | D | Restricted Stock Units | 597 | 0.00 | — | 89,417 | — | ↗ |
| 2023-12-12 | GRAVES JEFFREY A | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-11-01 | De Witte Jan | Director / Officer | M-Exempt | A | Common Stock | 9,814 | 0.00 | — | 22,612 | — | ↗ |
| 2023-09-01 | Veillon-Berteloot Chantal | Officer | A-Award | A | Common Stock | 4,678 | 0.00 | — | 4,678 | — | ↗ |
| 2023-08-23 | Veillon-Berteloot Chantal | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-08-09 | Mosebrook Jeffrey | Officer | S-Sale | D | Common Stock | 1,177 | 44.46 | 52.3K | 23,458 | — | ↗ |
| 2023-07-03 | Mosebrook Jeffrey | Officer | A-Award | A | Common Stock | 12,196 | 0.00 | — | 24,635 | — | ↗ |
| 2023-07-03 | Knight Lea Daniels | Officer | A-Award | A | Common Stock | 18,293 | 0.00 | — | 18,293 | — | ↗ |
| 2023-06-28 | Knight Lea Daniels | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-06-01 | Schwartz Eric | Officer | P-Purchase | A | Common Stock | 2,640 | 37.89 | 100.0K | 48,597 | — | ↗ |
| 2023-06-01 | De Witte Jan | Director / Officer | P-Purchase | A | Common Stock | 7,792 | 38.50 | 300.0K | 12,798 | — | ↗ |
| 2023-05-13 | BRADLEY KEITH | Director | F-InKind | D | Common Stock | 29 | 49.05 | 1.4K | 61,635 | — | ↗ |
| 2023-05-12 | SCHADE CHRISTIAN S | Director | A-Award | A | Common Stock | 4,486 | 0.00 | — | 54,807 | — | ↗ |
| 2023-05-12 | Murphy Raymond G. | Director | A-Award | A | Common Stock | 4,486 | 0.00 | — | 45,311 | — | ↗ |
| 2023-05-12 | Lo Renee Wonlai | Director | A-Award | A | Common Stock | 4,486 | 0.00 | — | 7,455 | — | ↗ |
| 2023-05-12 | HILL BARBARA B | Director | A-Award | A | Common Stock | 4,486 | 0.00 | — | 88,463 | — | ↗ |
| 2023-05-12 | ESSIG STUART | Director | A-Award | A | Common Stock | 5,505 | 0.00 | — | 1,152,329 | — | ↗ |
| 2023-05-12 | Clay Shaundra | Director | A-Award | A | Common Stock | 4,486 | 0.00 | — | 13,227 | — | ↗ |
| 2023-05-12 | BRADLEY KEITH | Director | A-Award | A | Common Stock | 816 | 0.00 | — | 61,664 | — | ↗ |
| 2023-03-13 | Schwartz Eric | Officer | F-InKind | D | Common Stock | 416 | 62.61 | 26.0K | 45,957 | — | ↗ |
| 2023-03-13 | Mosebrook Jeffrey | Officer | F-InKind | D | Common Stock | 64 | 52.61 | 3.4K | 12,439 | — | ↗ |
| 2023-03-13 | McBreen Michael J. | Officer | F-InKind | D | Common Stock | 655 | 52.61 | 34.5K | 42,750 | — | ↗ |
| 2023-03-13 | Evoli Lisa | Officer | F-InKind | D | Common Stock | 300 | 52.61 | 15.8K | 18,446 | — | ↗ |
| 2023-03-13 | DAVIS ROBERT T. JR. | Officer | F-InKind | D | Common Stock | 1,010 | 52.61 | 53.1K | 45,784 | — | ↗ |
| 2023-03-12 | Schwartz Eric | Officer | F-InKind | D | Common Stock | 338 | 52.87 | 17.9K | 47,288 | — | ↗ |
| 2023-03-12 | Mosebrook Jeffrey | Officer | F-InKind | D | Common Stock | 106 | 52.87 | 5.6K | 12,828 | — | ↗ |
| 2023-03-12 | McBreen Michael J. | Officer | F-InKind | D | Common Stock | 751 | 52.87 | 39.7K | 44,283 | — | ↗ |
| 2023-03-12 | Evoli Lisa | Officer | F-InKind | D | Common Stock | 448 | 52.87 | 23.7K | 19,929 | — | ↗ |
| 2023-03-12 | DAVIS ROBERT T. JR. | Officer | F-InKind | D | Common Stock | 755 | 52.87 | 39.9K | 47,253 | — | ↗ |
| 2023-03-11 | Schwartz Eric | Officer | F-InKind | D | Common Stock | 2,393 | 52.87 | 126.5K | 49,829 | — | ↗ |
| 2023-03-11 | Mosebrook Jeffrey | Officer | F-InKind | D | Common Stock | 130 | 52.87 | 6.9K | 12,934 | — | ↗ |
| 2023-03-11 | McBreen Michael J. | Officer | F-InKind | D | Common Stock | 857 | 52.87 | 45.3K | 45,525 | — | ↗ |
| 2023-03-11 | Evoli Lisa | Officer | F-InKind | D | Common Stock | 277 | 52.87 | 14.6K | 20,377 | — | ↗ |
| 2023-03-11 | De Witte Jan | Director / Officer | M-Exempt | D | Restricted Stock Units | 205 | 0.00 | — | 99,828 | — | ↗ |
| 2023-03-11 | DAVIS ROBERT T. JR. | Officer | F-InKind | D | Common Stock | 458 | 52.87 | 24.2K | 49,689 | — | ↗ |
| 2023-03-10 | Singh Harvinder | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 8,990 | 52.87 | 475.3K | 8,990 | — | ↗ |
| 2023-03-10 | Schwartz Eric | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 12,419 | 52.87 | 656.6K | 12,419 | — | ↗ |
| 2023-03-10 | Mosebrook Jeffrey | Officer | A-Award | A | Common Stock | 1,256 | 0.00 | — | 13,177 | — | ↗ |
| 2023-03-10 | McBreen Michael J. | Officer | A-Award | A | Common Stock | 8,128 | 0.00 | — | 46,382 | — | ↗ |
| 2023-03-10 | Evoli Lisa | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 6,201 | 52.87 | 327.8K | 6,201 | — | ↗ |
| 2023-03-10 | De Witte Jan | Director / Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 63,717 | 52.87 | 3.37M | 63,717 | — | ↗ |
| 2023-03-10 | DAVIS ROBERT T. JR. | Officer | A-Award | A | Common Stock | 4,227 | 0.00 | — | 50,147 | — | ↗ |
| 2023-03-07 | McBreen Michael J. | Officer | S-Sale | D | Common Stock | 1,843 | 54.29 | 100.1K | 28,796 | — | ↗ |
| 2023-03-02 | McBreen Michael J. | Officer | F-InKind | D | Common Stock | 723 | 55.09 | 39.8K | 30,639 | — | ↗ |
| 2023-03-01 | DAVIS ROBERT T. JR. | Officer | S-Sale | D | Common Stock | 1,566 | 55.21 | 86.5K | 45,920 | — | ↗ |
| 2023-02-27 | Evoli Lisa | Officer | S-Sale | D | Common Stock | 3,767 | 57.00 | 214.7K | 18,605 | — | ↗ |
| 2023-02-13 | Schwartz Eric | Officer | A-Award | A | Common Stock | 5,641 | 0.00 | — | 47,152 | — | ↗ |
| 2023-02-13 | Mosebrook Jeffrey | Officer | A-Award | A | Common Stock | 510 | 0.00 | — | 9,062 | — | ↗ |
| 2023-02-13 | McBreen Michael J. | Officer | A-Award | A | Common Stock | 1,680 | 0.00 | — | 29,443 | — | ↗ |
| 2023-02-13 | Evoli Lisa | Officer | A-Award | A | Common Stock | 1,552 | 0.00 | — | 19,549 | — | ↗ |
| 2023-02-13 | De Witte Jan | Director / Officer | A-Award | A | Common Stock | 8,848 | 0.00 | — | 8,848 | — | ↗ |
| 2023-02-13 | DAVIS ROBERT T. JR. | Officer | A-Award | A | Common Stock | 1,067 | 0.00 | — | 42,258 | — | ↗ |
| 2023-01-18 | De Witte Jan | Officer | M-Exempt | A | Common Stock | 431 | 0.00 | — | 431 | — | ↗ |
| 2022-12-08 | Mosebrook Jeffrey | Officer | S-Sale | D | Common Stock | 279 | 56.22 | 15.7K | 8,552 | — | ↗ |
| 2022-11-01 | De Witte Jan | Officer | A-Award | A | Restricted Stock Units | 29,441 | 0.00 | — | 74,456 | — | ↗ |
| 2022-10-31 | ESSIG STUART | Director | — | I | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-10-12 | Singh Harvinder | Officer | A-Award | A | Restricted Stock Units | 11,965 | 0.00 | — | 11,965 | — | ↗ |
| 2022-10-03 | Singh Harvinder | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-08-10 | Evoli Lisa | Officer | S-Sale | D | Common Stock | 1,165 | 55.81 | 65.0K | 17,997 | — | ↗ |
| 2022-08-05 | Murphy Raymond G. | Director | S-Sale | D | Common Stock | 8,000 | 55.78 | 446.3K | 40,825 | — | ↗ |
| 2022-08-03 | Evoli Lisa | Officer | F-InKind | D | Common Stock | 293 | 55.34 | 16.2K | 19,162 | — | ↗ |
| 2022-08-02 | Mosebrook Jeffrey | Officer | S-Sale | D | Common Stock | 437 | 56.78 | 24.8K | 8,831 | — | ↗ |
| 2022-08-01 | McBreen Michael J. | Officer | F-InKind | D | Common Stock | 599 | 56.87 | 34.1K | 25,289 | — | ↗ |
| 2022-08-01 | Evoli Lisa | Officer | F-InKind | D | Common Stock | 456 | 56.87 | 25.9K | 19,455 | — | ↗ |
| 2022-07-27 | Lo Renee Wonlai | Director | A-Award | A | Common Stock | 2,969 | 0.00 | — | 2,969 | — | ↗ |
| 2022-07-18 | Lo Renee Wonlai | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-07-01 | Coleman Glenn | Officer | F-InKind | D | Common Stock | 6,666 | 55.00 | 366.6K | 34,622 | — | ↗ |
| 2022-07-01 | Anderson Carrie L | Officer | F-InKind | D | Common Stock | 4,425 | 55.00 | 243.4K | 57,811 | — | ↗ |
| 2022-06-15 | Evoli Lisa | Officer | S-Sale | D | Common Stock | 900 | 55.93 | 50.3K | 19,911 | — | ↗ |
| 2022-05-24 | Evoli Lisa | Officer | S-Sale | D | Common Stock | 250 | 59.85 | 15.0K | 20,811 | — | ↗ |
| 2022-05-13 | SCHADE CHRISTIAN S | Director | A-Award | A | Common Stock | 3,456 | 0.00 | — | 50,321 | — | ↗ |
| 2022-05-13 | Murphy Raymond G. | Director | A-Award | A | Common Stock | 3,456 | 0.00 | — | 48,825 | — | ↗ |
| 2022-05-13 | MOREL DONALD E JR | Director | A-Award | A | Common Stock | 3,456 | 0.00 | — | 55,753 | — | ↗ |
| 2022-05-13 | HILL BARBARA B | Director | A-Award | A | Common Stock | 3,456 | 0.00 | — | 82,346 | — | ↗ |
| 2022-05-13 | ESSIG STUART | Director | A-Award | A | Common Stock | 4,215 | 0.00 | — | 1,146,824 | — | ↗ |
| 2022-05-13 | Clay Shaundra | Director | A-Award | A | Common Stock | 3,456 | 0.00 | — | 8,741 | — | ↗ |
| 2022-05-13 | BRADLEY KEITH | Director | F-InKind | D | Common Stock | 131 | 59.32 | 7.8K | 56,362 | — | ↗ |
| 2022-04-04 | Coleman Glenn | Officer | S-Sale | D | Common Stock | 6,268 | 66.04 | 413.9K | 41,288 | — | ↗ |
| 2022-03-23 | Tru St Partnership, L.P. | 10% Owner | S-Sale | D | Common Stock | 150,000 | 64.67 | 9.70M | 8,515,930 | — | ↗ |
| 2022-03-13 | Schwartz Eric | Officer | F-InKind | D | Common Stock | 691 | 65.11 | 45.0K | 38,883 | — | ↗ |
| 2022-03-13 | Mosebrook Jeffrey | Officer | F-InKind | D | Common Stock | 44 | 65.11 | 2.9K | 9,726 | — | ↗ |
| 2022-03-13 | Evoli Lisa | Officer | F-InKind | D | Common Stock | 430 | 65.11 | 28.0K | 21,765 | — | ↗ |
| 2022-03-13 | DAVIS ROBERT T. JR. | Officer | F-InKind | D | Common Stock | 297 | 65.11 | 19.3K | 40,703 | — | ↗ |
| 2022-03-13 | Anderson Carrie L | Officer | F-InKind | D | Common Stock | 807 | 65.11 | 52.5K | 64,532 | — | ↗ |
| 2022-03-12 | Schwartz Eric | Officer | F-InKind | D | Common Stock | 349 | 65.11 | 22.7K | 40,264 | — | ↗ |
| 2022-03-12 | Mosebrook Jeffrey | Officer | F-InKind | D | Common Stock | 120 | 65.11 | 7.8K | 10,154 | — | ↗ |
| 2022-03-12 | Evoli Lisa | Officer | F-InKind | D | Common Stock | 394 | 65.11 | 25.7K | 23,155 | — | ↗ |
| 2022-03-12 | DAVIS ROBERT T. JR. | Officer | F-InKind | D | Common Stock | 1,109 | 65.11 | 72.2K | 42,000 | — | ↗ |
| 2022-03-12 | Anderson Carrie L | Officer | F-InKind | D | Common Stock | 436 | 65.11 | 28.4K | 67,781 | — | ↗ |
| 2022-03-11 | Schwartz Eric | Officer | F-InKind | D | Common Stock | 1,488 | 65.11 | 96.9K | 37,395 | — | ↗ |
| 2022-03-11 | Mosebrook Jeffrey | Officer | F-InKind | D | Common Stock | 240 | 65.11 | 15.6K | 9,914 | — | ↗ |
| 2022-03-11 | McBreen Michael J. | Officer | F-InKind | D | Common Stock | 1,083 | 65.11 | 70.5K | 25,888 | — | ↗ |
| 2022-03-11 | Evoli Lisa | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 5,553 | 65.11 | 361.6K | 5,553 | — | ↗ |
| 2022-03-11 | De Witte Jan | Officer | A-Award | A | Restricted Stock Units | 15,359 | 0.00 | — | 45,015 | — | ↗ |
| 2022-03-11 | DAVIS ROBERT T. JR. | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 9,193 | 65.11 | 598.6K | 9,193 | — | ↗ |
| 2022-03-11 | Coleman Glenn | Officer | F-InKind | D | Common Stock | 5,338 | 65.11 | 347.6K | 47,556 | — | ↗ |
| 2022-03-11 | Anderson Carrie L | Officer | A-Award | A | Common Stock | 11,519 | 0.00 | — | 68,217 | — | ↗ |
| 2022-03-02 | McBreen Michael J. | Officer | F-InKind | D | Common Stock | 466 | 67.59 | 31.5K | 19,261 | — | ↗ |
| 2022-03-01 | Schwartz Eric | Officer | F-InKind | D | Common Stock | 1,712 | 66.32 | 113.5K | 31,912 | — | ↗ |
| 2022-02-28 | Evoli Lisa | Officer | S-Sale | D | Common Stock | 1,254 | 67.03 | 84.1K | 14,058 | — | ↗ |
| 2022-02-11 | Schwartz Eric | Officer | A-Award | A | Common Stock | 2,520 | 0.00 | — | 25,605 | — | ↗ |
| 2022-02-11 | Mosebrook Jeffrey | Officer | A-Award | A | Common Stock | 595 | 0.00 | — | 6,603 | — | ↗ |
| 2022-02-11 | McBreen Michael J. | Officer | A-Award | A | Common Stock | 1,458 | 0.00 | — | 11,195 | — | ↗ |
| 2022-02-11 | Evoli Lisa | Officer | A-Award | A | Common Stock | 1,566 | 0.00 | — | 8,916 | — | ↗ |
| 2022-02-11 | DAVIS ROBERT T. JR. | Officer | A-Award | A | Common Stock | 2,956 | 0.00 | — | 25,107 | — | ↗ |
| 2022-02-11 | Coleman Glenn | Officer | A-Award | A | Common Stock | 5,892 | 0.00 | — | 34,046 | — | ↗ |
| 2022-02-11 | Anderson Carrie L | Officer | A-Award | A | Common Stock | 8,904 | 0.00 | — | 50,462 | — | ↗ |
| 2022-02-09 | Tru St Partnership, L.P. | 10% Owner | S-Sale | D | Common Stock | 75,000 | 65.82 | 4.94M | 8,665,930 | — | ↗ |
| 2022-01-18 | De Witte Jan | Director / Officer | A-Award | A | Restricted Stock Units | 29,656 | 0.00 | — | 29,656 | — | ↗ |
| 2021-12-16 | Tru St Partnership, L.P. | 10% Owner | S-Sale | D | Common Stock | 75,000 | 64.28 | 4.82M | 8,740,930 | — | ↗ |
| 2021-12-03 | Schwartz Eric | Officer | F-InKind | D | Common Stock | 2,414 | 62.69 | 151.3K | 23,085 | — | ↗ |
| 2021-12-01 | De Witte Jan | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-11-18 | Tru St Partnership, L.P. | 10% Owner | S-Sale | D | Common Stock | 75,000 | 68.59 | 5.14M | 8,815,930 | — | ↗ |
| 2021-11-10 | Mosebrook Jeffrey | Officer | S-Sale | D | Common Stock | 700 | 70.88 | 49.6K | 6,008 | — | ↗ |
| 2021-11-05 | McBreen Michael J. | Officer | S-Sale | D | Common Stock | 3,450 | 71.59 | 247.0K | 9,737 | — | ↗ |
| 2021-11-02 | Coleman Glenn | Officer | S-Sale | D | Common Stock | 4,275 | 74.00 | 316.4K | 27,781 | — | ↗ |
| 2021-10-20 | Tru St Partnership, L.P. | 10% Owner | S-Sale | D | Common Stock | 200,000 | 69.81 | 13.96M | 8,890,930 | — | ↗ |
Executive team
Executive compensation
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Mojdeh Poul President and Chief Executive Officer and Director | 1.01M | 350.4K | 5.22M | 2.25M | 174.6K | 371.1K | 9.38M | 79.67% | ↗ |
| 2 | 2025 | Lea Knight Executive Vice President and Chief Financial Officer | 638.6K | 154.9K | 1.50M | 499.6K | 77.2K | 14.0K | 2.88M | 69.31% | ↗ |
| 3 | 2025 | Michael J. McBreen Executive Vice President, President, Codman Specialty Surgical | 643.8K | 212.4K | 1.33M | 442.6K | 72.8K | 14.0K | 2.71M | 65.25% | ↗ |
| 4 | 2025 | Robert T. Davis, Jr Executive Vice President, President, Tissue Technologies | 583.4K | 69.6K | 892.7K | 297.6K | 55.4K | 14.0K | 1.91M | 62.23% | ↗ |
| 5 | 2025 | Harvinder Singh Executive Vice President, President, International | 564.0K | 91.2K | 683.1K | 227.7K | 45.4K | 14.0K | 1.63M | 56.04% | ↗ |
| 6 | 2025 | Jan De Witte Former President and Chief Executive Officer and Director | 42.3K | — | — | — | — | 240.4K | 282.7K | 0.00% | ↗ |
| 7 | 2024 | Jan De Witte Former President and Chief Executive Officer and Director | 969.0K | — | 4.50M | 1.50M | 491.3K | 34.4K | 7.49M | 80.06% | ↗ |
| 8 | 2024 | Jan De Witte President and Chief Executive Officer and Director | 969.0K | — | 4.50M | 1.50M | 491.3K | 34.4K | 7.49M | 80.06% | ↗ |
| 9 | 2024 | Michael J. McBreen Executive Vice President, President, Codman Specialty Surgical | 638.7K | 222.7K | 1.63M | 442.6K | 215.0K | 13.5K | 3.16M | 65.51% | ↗ |
| 10 | 2024 | Lea Knight Executive Vice President and Chief Financial Officer | 616.7K | 281.9K | 1.58M | 428.2K | 220.3K | 13.8K | 3.15M | 63.99% | ↗ |
| 11 | 2024 | Harvinder Singh Executive Vice President, President, International | 511.1K | 134.3K | 1.38M | 258.6K | 129.7K | 214.6K | 2.62M | 62.28% | ↗ |
| 12 | 2024 | Robert T. Davis, Jr Executive Vice President, President, Tissue Technologies | 544.9K | 134.8K | 1.20M | 234.6K | 130.2K | 13.8K | 2.26M | 63.59% | ↗ |
| 13 | 2023 | Jan De Witte President and Chief Executive Officer and Director | 875.5K | — | 4.13M | 1.38M | — | 13.2K | 6.39M | 86.09% | ↗ |
| 14 | 2023 | Jan De Witte Former President and Chief Executive Officer and Director | 875.5K | — | 4.13M | 1.38M | — | 13.2K | 6.39M | 86.09% | ↗ |
| 15 | 2023 | Michael J. McBreen Executive Vice President, President, Codman Specialty Surgical | 598.1K | — | 1.79M | 429.7K | — | 13.2K | 2.83M | 78.40% | ↗ |
| 16 | 2023 | Lea Knight Executive Vice President and Chief Financial Officer | 295.4K | 350.0K | 1.00M | — | — | 27.8K | 1.67M | 59.77% | ↗ |
| 17 | 2023 | Eric I. Schwartz Executive Vice President, Chief Legal Officer & Secretary | 536.3K | — | 804.1K | 268.0K | — | 13.2K | 1.62M | 66.11% | ↗ |
| 18 | 2023 | Robert T. Davis, Jr Executive Vice President, President, Tissue Technologies | 516.0K | — | 670.4K | 223.4K | — | 13.1K | 1.42M | 62.82% | ↗ |
| 19 | 2023 | Jeffrey Mosebrook Senior Vice President, Finance and Interim PFO | 368.1K | 111.9K | 760.2K | — | — | 13.2K | 1.25M | 60.65% | ↗ |
| 20 | 2023 | Carrie L. Anderson Former Executive Vice President and Chief Financial Officer | 64.7K | — | — | — | — | 2.6K | 67.3K | 0.00% | ↗ |
| 21 | 2022 | Jan De Witte President and Chief Executive Officer and Director | 850.0K | — | 6.50M | 1.00M | 813.5K | 156.4K | 9.32M | 80.47% | ↗ |
| 22 | 2022 | Glenn G. Coleman Former Executive Vice President and Chief Operating Officer | 463.5K | — | 1.39M | 463.5K | 430.1K | 1.68M | 4.43M | 41.89% | ↗ |
| 23 | 2022 | Eric I. Schwartz Executive Vice President, Chief Legal Officer & Secretary | 525.0K | — | 1.91M | 637.5K | 310.0K | 12.2K | 3.40M | 75.06% | ↗ |
| 24 | 2022 | Carrie L. Anderson Former Executive Vice President and Chief Financial Officer | 565.4K | — | 1.97M | 406.0K | — | 12.2K | 2.95M | 80.43% | ↗ |
| 25 | 2022 | Michael J. McBreen Executive Vice President, President, Codman Specialty Surgical | 494.5K | — | 1.15M | 216.9K | 274.1K | 12.2K | 2.15M | 63.66% | ↗ |
| 26 | 2022 | Robert T. Davis, Jr Executive Vice President, President, Tissue Technologies | 498.0K | — | 938.5K | 212.8K | 271.0K | 12.2K | 1.93M | 59.57% | ↗ |
| 27 | 2021 | Peter J. Arduini President and Chief Executive Officer and Director | 956.3K | — | 5.75M | 1.50M | 1.62M | 11.6K | 9.84M | 73.69% | ↗ |
| 28 | 2021 | Glenn G. Coleman Executive Vice President and Chief Operating Officer | 613.3K | — | 1.76M | 463.5K | 688.0K | 11.3K | 3.54M | 62.90% | ↗ |
| 29 | 2021 | Glenn G. Coleman Former Executive Vice President and Chief Operating Officer | 613.3K | — | 1.76M | 463.5K | 688.0K | 11.3K | 3.54M | 62.90% | ↗ |
| 30 | 2021 | Carrie L. Anderson Former Executive Vice President and Chief Financial Officer | 518.5K | — | 1.25M | 328.1K | 515.0K | 28.1K | 2.64M | 59.74% | ↗ |
| 31 | 2021 | Carrie L. Anderson Executive Vice President and Chief Financial Officer | 518.5K | — | 1.25M | 328.1K | 515.0K | 28.1K | 2.64M | 59.74% | ↗ |
| 32 | 2021 | Robert T. Davis, Jr Executive Vice President, President, Tissue Technologies | 487.0K | — | 876.0K | 208.6K | 375.0K | 11.3K | 1.96M | 55.39% | ↗ |
| 33 | 2021 | Michael J. McBreen Executive Vice President, President, Codman Specialty Surgical | 460.0K | — | 827.5K | 197.0K | 385.0K | 10.9K | 1.88M | 54.48% | ↗ |
| 34 | 2021 | Jan D. De Witte President and Chief Executive Officer and Director | 58.8K | — | — | — | 144.4K | 48.5K | 251.8K | 0.00% | ↗ |
| 35 | 2021 | Jan De Witte President and Chief Executive Officer and Director | 58.8K | — | — | — | 144.4K | 48.5K | 251.8K | 0.00% | ↗ |
| 36 | 2020 | Peter J. Arduini President and Chief Executive Officer and Director | 848.1K | — | 4.20M | 1.80M | 882.0K | 10.6K | 7.74M | 77.51% | ↗ |
| 37 | 2020 | Glenn G. Coleman Executive Vice President and Chief Operating Officer | 559.6K | — | 1.33M | 570.0K | 360.0K | 8.3K | 2.83M | 67.19% | ↗ |
| 38 | 2020 | Glenn G. Coleman Former Executive Vice President and Chief Operating Officer | 559.6K | — | 1.33M | 570.0K | 360.0K | 8.3K | 2.83M | 67.19% | ↗ |
| 39 | 2020 | Carrie L. Anderson Former Executive Vice President and Chief Financial Officer | 466.3K | — | 875.0K | 375.0K | 262.5K | 81.9K | 2.06M | 60.66% | ↗ |
| 40 | 2020 | Carrie L. Anderson Executive Vice President and Chief Financial Officer | 466.3K | — | 875.0K | 375.0K | 262.5K | 81.9K | 2.06M | 60.66% | ↗ |
| 41 | 2020 | Robert T. Davis, Jr Executive Vice President, President, Tissue Technologies | 449.6K | — | 483.1K | 207.0K | 214.5K | 11.4K | 1.37M | 50.53% | ↗ |
| 42 | 2020 | Michael J. McBreen Executive Vice President, President, Codman Specialty Surgical | 385.3K | — | 547.6K | 127.5K | 202.5K | 11.4K | 1.27M | 52.98% | ↗ |
| 43 | 2019 | Peter J. Arduini President and Chief Executive Officer and Director | 975.0K | — | 3.99M | 1.71M | 1.18M | 8.4K | 7.86M | 72.52% | ↗ |
| 44 | 2019 | Glenn G. Coleman Executive Vice President and Chief Operating Officer | 585.4K | — | 1.65M | 387.5K | 482.0K | 11.2K | 3.12M | 65.43% | ↗ |
| 45 | 2019 | Carrie L. Anderson Executive Vice President and Chief Financial Officer | 259.6K | 225.0K | 1.70M | — | 205.0K | 16.3K | 2.41M | 70.66% | ↗ |
| 46 | 2019 | Eric I. Schwartz Executive Vice President, Chief Legal Officer and Secretary | 425.0K | — | 1.39M | 165.8K | 256.3K | 11.2K | 2.25M | 69.15% | ↗ |
| 47 | 2019 | Robert T. Davis, Jr Executive Vice President, President, Orthopedics and Tissue Technologies | 473.2K | — | 453.6K | 194.4K | 258.0K | 11.2K | 1.39M | 46.60% | ↗ |
| 48 | 2019 | Robert T. Davis, Jr Executive Vice President, President, Tissue Technologies | 473.2K | — | 453.6K | 194.4K | 258.0K | 11.2K | 1.39M | 46.60% | ↗ |
| 49 | 2019 | Daniel L. Reuvers Executive Vice President, President, Codman Surgical Solutions | 445.3K | — | 416.6K | 178.5K | 290.0K | 11.2K | 1.34M | 44.36% | ↗ |
| 50 | 2018 | Peter J. Arduini President and Chief Executive Officer and Director | 947.9K | — | 3.82M | 1.64M | 1.23M | 17.2K | 7.65M | 71.26% | ↗ |
| 51 | 2018 | Richard D. Gorelick Former Corporate Vice President, General Counsel, Administration and Secretary | 406.1K | — | 245.1K | 105.0K | — | 2.01M | 2.77M | 12.65% | ↗ |
| 52 | 2018 | Glenn G. Coleman Corporate Vice President and Chief Financial Officer | 556.2K | — | 869.4K | 372.6K | 480.7K | 15.7K | 2.29M | 54.13% | ↗ |
| 53 | 2018 | Glenn G. Coleman Executive Vice President and Chief Operating Officer | 556.2K | — | 869.4K | 372.6K | 480.7K | 15.7K | 2.29M | 54.13% | ↗ |
| 54 | 2018 | Daniel L. Reuvers Corporate Vice President, President, Codman Surgical Solutions | 418.9K | — | 892.1K | 168.0K | 326.0K | 13.4K | 1.82M | 58.30% | ↗ |
| 55 | 2018 | Daniel L. Reuvers Executive Vice President, President, Codman Surgical Solutions | 418.9K | — | 892.1K | 168.0K | 326.0K | 13.4K | 1.82M | 58.30% | ↗ |
| 56 | 2018 | Robert T. Davis, Jr Executive Vice President, President, Tissue Technologies | 458.4K | — | 437.6K | 187.5K | 272.0K | 14.0K | 1.37M | 45.65% | ↗ |
| 57 | 2018 | Robert T. Davis, Jr Executive Vice President, President, Orthopedics and Tissue Technologies | 458.4K | — | 437.6K | 187.5K | 272.0K | 14.0K | 1.37M | 45.65% | ↗ |
| 58 | 2018 | Robert T. Davis, Jr Corporate Vice President, President, Orthopedics and Tissue Technologies | 458.4K | — | 437.6K | 187.5K | 272.0K | 14.0K | 1.37M | 45.65% | ↗ |
| 59 | 2018 | Eric I. Schwartz Corporate Vice President, General Counsel and Secretary | 57.2K | — | 900.0K | — | — | 180.0K | 1.14M | 79.14% | ↗ |
| 60 | 2018 | Eric I. Schwartz Executive Vice President, Chief Legal Officer and Secretary | 57.2K | 180.0K | 900.0K | — | — | — | 1.14M | 79.14% | ↗ |
| 61 | 2017 | Peter J. Arduini President and Chief Executive Officer and Director | 905.0K | — | 3.33M | 1.43M | 1.46M | 16.1K | 7.13M | 66.58% | ↗ |
| 62 | 2017 | Glenn G. Coleman Corporate Vice President and Chief Financial Officer | 536.3K | — | 805.0K | 345.0K | 590.0K | 11.0K | 2.29M | 50.28% | ↗ |
| 63 | 2017 | Glenn G. Coleman Executive Vice President and Chief Operating Officer | 536.3K | — | 805.0K | 345.0K | 590.0K | 11.0K | 2.29M | 50.28% | ↗ |
| 64 | 2017 | Robert T. Davis, Jr Corporate Vice President, President, Orthopedics and Tissue Technologies | 441.3K | — | 437.5K | 187.5K | 360.0K | 8.0K | 1.43M | 43.58% | ↗ |
| 65 | 2017 | Robert T. Davis, Jr Executive Vice President, President, Orthopedics and Tissue Technologies | 441.3K | — | 437.5K | 187.5K | 360.0K | 8.0K | 1.43M | 43.58% | ↗ |
| 66 | 2017 | Daniel L. Reuvers Corporate Vice President, President, Codman Surgical Solutions | 407.3K | — | 262.6K | 112.5K | 375.0K | 117.7K | 1.28M | 29.42% | ↗ |
| 67 | 2017 | Daniel L. Reuvers Executive Vice President, President, Codman Surgical Solutions | 407.3K | — | 262.6K | 112.5K | 375.0K | 117.7K | 1.28M | 29.42% | ↗ |
| 68 | 2017 | Richard D. Gorelick Former Corporate Vice President, General Counsel, Administration and Secretary | 394.7K | — | 220.5K | 94.5K | 315.0K | 11.6K | 1.04M | 30.40% | ↗ |
| 69 | 2017 | Richard D. Gorelick Corporate Vice President, General Counsel, Administration and Secretary | 394.7K | — | 220.5K | 94.5K | 315.0K | 11.6K | 1.04M | 30.40% | ↗ |
| 70 | 2016 | Peter J. Arduini President and Chief Executive Officer and Director | 878.8K | — | 3.15M | 1.56M | 1.40M | 9.6K | 6.99M | 67.28% | ↗ |
| 71 | 2016 | Glenn G. Coleman Corporate Vice President and Chief Financial Officer | 481.6K | — | 490.1K | 592.0K | 400.0K | 10.0K | 1.97M | 54.83% | ↗ |
| 72 | 2016 | Robert T. Davis, Jr Corporate Vice President, President, Orthopedics and Tissue Technologies | 400.5K | — | 336.1K | 415.9K | 300.0K | 10.9K | 1.46M | 51.39% | ↗ |
| 73 | 2016 | Daniel L. Reuvers Corporate Vice President, President, Codman Surgical Solutions | 328.2K | — | 133.8K | 216.0K | 205.0K | 20.0K | 903.0K | 38.74% | ↗ |
| 74 | 2016 | Daniel L. Reuvers Corporate Vice President, President, Specialty Surgical Solutions | 328.2K | — | 133.8K | 216.0K | 205.0K | 20.0K | 903.0K | 38.74% | ↗ |
| 75 | 2016 | Richard D. Gorelick Corporate Vice President, General Counsel, Administration and Secretary | 384.7K | — | 184.9K | 91.3K | 206.0K | 10.0K | 876.8K | 31.50% | ↗ |
| 76 | 2016 | Richard D. Gorelick Former Corporate Vice President, General Counsel, Administration and Secretary | 384.7K | — | 184.9K | 91.3K | 206.0K | 10.0K | 876.8K | 31.50% | ↗ |
| 77 | 2015 | Peter J. Arduini President and Chief Executive Officer and Director | 885.6K | — | 3.05M | 2.27M | 1.39M | 7.8K | 7.60M | 69.98% | ↗ |
| 78 | 2015 | Glenn G. Coleman Corporate Vice President and Chief Financial Officer | 478.1K | — | 397.0K | 480.0K | 348.0K | 7.8K | 1.71M | 51.26% | ↗ |
| 79 | 2015 | Mark Augusti Corporate Vice President, President — Orthopedics and Tissue Technologies | 396.3K | 95.0K | 383.5K | — | 230.4K | 7.8K | 1.11M | 34.46% | ↗ |
| 80 | 2015 | Richard D. Gorelick Corporate Vice President, General Counsel, Administration and Secretary, Interim Chief Human Resources Officer | 388.7K | — | 188.8K | 228.1K | 190.0K | 4.1K | 999.7K | 41.70% | ↗ |
| 81 | 2015 | Richard D. Gorelick Corporate Vice President, General Counsel, Administration and Secretary | 388.7K | — | 188.8K | 228.1K | 190.0K | 4.1K | 999.7K | 41.70% | ↗ |
| 82 | 2015 | Robert T. Davis, Jr Corporate Vice President, President — Specialty Surgical Solutions | 391.6K | — | 298.0K | 60.5K | 232.5K | 4.1K | 986.7K | 36.33% | ↗ |
| 83 | 2015 | Robert T. Davis, Jr Corporate Vice President, President, Orthopedics and Tissue Technologies | 391.6K | — | 298.0K | 60.5K | 232.5K | 4.1K | 986.7K | 36.33% | ↗ |
| 84 | 2014 | Peter J. Arduini President and Chief Executive Officer and Director | 827.8K | — | 2.45M | 1.05M | 1.13M | 23.3K | 5.48M | 63.89% | ↗ |
| 85 | 2014 | Peter J. Arduini President and Chief Executive Officer and Director | 827.8K | — | 2.45M | 1.05M | 1.13M | 23.3K | 5.48M | 63.89% | ↗ |
| 86 | 2014 | John B. Henneman, III Former Corporate Vice President, Finance and Administration, and Chief Financial Officer | 432.9K | — | 1.50M | — | 378.7K | 1.07M | 3.38M | 44.22% | ↗ |
| 87 | 2014 | Glenn G. Coleman Corporate Vice President and Chief Financial Officer | 287.3K | 250.0K | 980.1K | 420.0K | 190.0K | — | 2.13M | 65.81% | ↗ |
| 88 | 2014 | Robert D. Paltridge Former Corporate Vice President, President — Advanced Wound Care | 180.9K | — | 208.6K | — | — | 758.5K | 1.15M | 18.17% | ↗ |
| 89 | 2014 | Robert T. Davis, Jr Corporate Vice President, President, Orthopedics and Tissue Technologies | 344.7K | — | 278.1K | — | 175.0K | 104.6K | 902.4K | 30.82% | ↗ |
| 90 | 2014 | Robert T. Davis, Jr Corporate Vice President, President — Specialty Surgical Solutions | 344.7K | — | 278.1K | — | 175.0K | 104.6K | 902.4K | 30.82% | ↗ |
| 91 | 2014 | Robert T. Davis, Jr Corporate Vice President, President — Specialty Surgical Solutions | 344.7K | — | 278.1K | — | 175.0K | 104.6K | 902.4K | 30.82% | ↗ |
| 92 | 2014 | Richard D. Gorelick Corporate Vice President, General Counsel, Administration and Secretary | 364.2K | — | 251.3K | — | 141.0K | 4.1K | 760.6K | 33.03% | ↗ |
| 93 | 2014 | Richard D. Gorelick Corporate Vice President, General Counsel, Administration and Secretary | 364.2K | — | 251.3K | — | 141.0K | 4.1K | 760.6K | 33.03% | ↗ |
| 94 | 2014 | Richard D. Gorelick Corporate Vice President, General Counsel, Administration and Secretary, Interim Chief Human Resources Officer | 364.2K | — | 251.3K | — | 141.0K | 4.1K | 760.6K | 33.03% | ↗ |
| 95 | 2014 | John Mooradian Corporate Vice President, Global Operations and Supply | 363.0K | — | 248.6K | — | 140.0K | 4.1K | 755.7K | 32.89% | ↗ |
| 96 | 2013 | Peter J. Arduini President and Chief Executive Officer and Director | 787.1K | — | 1.74M | 450.0K | — | 3.8K | 2.98M | 73.45% | ↗ |
| 97 | 2013 | Peter J. Arduini President and Chief Executive Officer and Director | 787.1K | — | 1.74M | 450.0K | — | 3.8K | 2.98M | 73.45% | ↗ |
| 98 | 2013 | John B. Henneman, III Former Corporate Vice President, Finance and Administration, and Chief Financial Officer | 549.4K | — | 1.00M | — | — | 4.1K | 1.55M | 64.37% | ↗ |
| 99 | 2013 | John B. Henneman, III Corporate Vice President, Finance and Administration, and Chief Financial Officer | 549.4K | — | 1.00M | — | — | 4.1K | 1.55M | 64.37% | ↗ |
| 100 | 2013 | Robert T. Davis, Jr Corporate Vice President, President — Specialty Surgical Solutions | 335.1K | — | 175.1K | — | — | 4.1K | 514.3K | 34.04% | ↗ |
| 101 | 2013 | Robert T. Davis, Jr Corporate Vice President, President — Specialty Surgical Solutions | 335.1K | — | 175.1K | — | — | 4.1K | 514.3K | 34.04% | ↗ |
| 102 | 2013 | Robert T. Davis, Jr Corporate Vice President, President — Neurosurgery | 335.1K | — | 175.1K | — | — | 4.1K | 514.3K | 34.04% | ↗ |
| 103 | 2013 | Richard D. Gorelick Corporate Vice President, General Counsel, Administration and Secretary, Interim Chief Human Resources Officer | 355.7K | — | 139.0K | — | — | 4.1K | 498.8K | 27.87% | ↗ |
| 104 | 2013 | Richard D. Gorelick Corporate Vice President, General Counsel, Administration and Secretary | 355.7K | — | 139.0K | — | — | 4.1K | 498.8K | 27.87% | ↗ |
| 105 | 2013 | Brian Larkin Corporate Vice President, President — Global Spine Orthobiologics Head of Strategic Development | 336.6K | — | 130.1K | — | — | 4.1K | 470.8K | 27.63% | ↗ |
| 106 | 2013 | John Mooradian Corporate Vice President, Global Operations and Supply | 353.7K | — | 110.1K | — | — | 4.1K | 467.8K | 23.52% | ↗ |
| 107 | 2013 | Robert D. Paltridge Former Corporate Vice President, President — Advanced Wound Care | 328.0K | — | 125.1K | — | — | 4.1K | 457.1K | 27.36% | ↗ |
| 108 | 2012 | Peter J. Arduini President and Chief Executive Officer and Director | 722.1K | — | 4.54M | 2.83M | 400.0K | 17.6K | 8.51M | 86.61% | ↗ |
| 109 | 2012 | John B. Henneman, III Former Corporate Vice President, Finance and Administration, and Chief Financial Officer | 530.3K | — | 2.20M | — | 275.0K | 4.1K | 3.01M | 73.08% | ↗ |
| 110 | 2012 | John B. Henneman, III Corporate Vice President, Finance and Administration, and Chief Financial Officer (former Executive Vice President, Finance and Administration, and Chief Financial Officer) | 530.3K | — | 2.20M | — | 275.0K | 4.1K | 3.01M | 73.08% | ↗ |
| 111 | 2012 | John B. Henneman, III Corporate Vice President, Finance and Administration, and Chief Financial Officer | 530.3K | — | 2.20M | — | 275.0K | 4.1K | 3.01M | 73.08% | ↗ |
| 112 | 2012 | John Mooradian Corporate Vice President, Global Operations and Supply | 109.0K | 300.0K | 300.0K | — | 122.0K | — | 831.0K | 36.10% | ↗ |
| 113 | 2012 | John Mooradian Corporate Vice President, Global Operations and Supply | 109.0K | 300.0K | 300.0K | — | 122.0K | — | 831.0K | 36.10% | ↗ |
| 114 | 2012 | Richard D. Gorelick Corporate Vice President, General Counsel, Administration and Secretary | 345.2K | — | 180.0K | — | 138.7K | 4.1K | 668.1K | 26.95% | ↗ |
| 115 | 2012 | Richard D. Gorelick Corporate Vice President, General Counsel, Administration and Secretary | 345.2K | — | 180.0K | — | 138.7K | 4.1K | 668.1K | 26.95% | ↗ |
| 116 | 2012 | Robert D. Paltridge Former Corporate Vice President, President — Advanced Wound Care | 318.6K | — | 195.3K | — | 130.0K | 4.1K | 648.1K | 30.14% | ↗ |
| 117 | 2012 | Robert D. Paltridge Former Corporate Vice President, President — Advanced Wound Care | 318.6K | — | 195.3K | — | 130.0K | 4.1K | 648.1K | 30.14% | ↗ |
| 118 | 2012 | Stuart M. Essig Chairman of the Board of Directors (former Chief Executive Officer and former Executive Chairman of the Board) | 343.3K | — | 114.0K | — | — | 49.4K | 506.7K | 22.51% | ↗ |
| 119 | 2011 | Stuart M. Essig Executive Chairman and Former Chief Executive Officer | 749.0K | — | 10.72M | — | — | 2.9K | 11.48M | 93.45% | ↗ |
| 120 | 2011 | Stuart M. Essig Chairman of the Board of Directors (former Chief Executive Officer and former Executive Chairman of the Board) | 749.0K | — | 10.72M | — | — | 2.9K | 11.48M | 93.45% | ↗ |
| 121 | 2011 | Peter J. Arduini President and Chief Executive Officer | 600.0K | 400.0K | — | — | — | 157.2K | 1.16M | 0.00% | ↗ |
| 122 | 2011 | Peter J. Arduini President and Chief Executive Officer and Director | 600.0K | 400.0K | — | — | — | 157.2K | 1.16M | 0.00% | ↗ |
| 123 | 2011 | John B. Henneman, III Corporate Vice President, Finance and Administration, and Chief Financial Officer | 524.5K | — | — | — | — | 4.1K | 528.6K | 0.00% | ↗ |
| 124 | 2011 | John B. Henneman, III Executive Vice President, Finance and Administration, and Chief Financial Officer | 524.5K | — | — | — | — | 4.1K | 528.6K | 0.00% | ↗ |
| 125 | 2011 | John B. Henneman, III Corporate Vice President, Finance and Administration, and Chief Financial Officer (former Executive Vice President, Finance and Administration, and Chief Financial Officer) | 524.5K | — | — | — | — | 4.1K | 528.6K | 0.00% | ↗ |
| 126 | 2011 | Jerry E. Corbin Vice President, Corporate Controller and Principal Accounting Officer | 255.8K | — | 195.9K | — | 28.8K | 4.1K | 484.6K | 40.42% | ↗ |
| 127 | 2011 | Judith E. O’Grady Senior Vice President, Regulatory Affairs and Quality Systems, and Corporate Compliance Officer | 269.2K | — | 100.0K | — | 30.8K | 3.3K | 403.4K | 24.80% | ↗ |
| 128 | 2010 | Stuart M. Essig Executive Chairman and Former Chief Executive Officer | 698.5K | — | 5.18M | — | 300.0K | 2.9K | 6.19M | 83.81% | ↗ |
| 129 | 2010 | Stuart M. Essig Chairman of the Board of Directors (former Chief Executive Officer and former Executive Chairman of the Board) | 698.5K | — | 5.18M | — | 300.0K | 2.9K | 6.19M | 83.81% | ↗ |
| 130 | 2010 | Stuart M. Essig Chief Executive Officer | 698.5K | — | 5.18M | — | 300.0K | 2.9K | 6.19M | 83.81% | ↗ |
| 131 | 2010 | John B. Henneman, III Executive Vice President, Finance and Administration, and Chief Financial Officer | 499.2K | — | 3.00M | — | 250.0K | 2.9K | 3.75M | 79.96% | ↗ |
| 132 | 2010 | John B. Henneman, III Corporate Vice President, Finance and Administration, and Chief Financial Officer (former Executive Vice President, Finance and Administration, and Chief Financial Officer) | 499.2K | — | 3.00M | — | 250.0K | 2.9K | 3.75M | 79.96% | ↗ |
| 133 | 2010 | John B. Henneman, III Executive Vice President, Finance and Administration, and Chief Financial Officer | 499.2K | — | 3.00M | — | 250.0K | 2.9K | 3.75M | 79.96% | ↗ |
| 134 | 2010 | Peter J. Arduini President and Chief Executive Officer | 92.3K | 500.0K | 1.50M | — | — | — | 2.09M | 71.69% | ↗ |
| 135 | 2010 | Peter J. Arduini President and Chief Executive Officer and Director | 92.3K | 500.0K | 1.50M | — | — | — | 2.09M | 71.69% | ↗ |
| 136 | 2010 | Peter Arduini President and Chief Operating Officer | 92.3K | 500.0K | 1.50M | — | — | — | 2.09M | 71.69% | ↗ |
| 137 | 2010 | Gerard S. Carlozzi Former Executive Vice President and Chief Operating Officer | 499.2K | — | 237.5K | — | 250.0K | — | 986.7K | 24.07% | ↗ |
| 138 | 2010 | Judith E. O’Grady Senior Vice President, Regulatory Affairs and Quality Systems, and Corporate Compliance Officer | 248.7K | — | 58.7K | — | 63.8K | 3.9K | 375.0K | 15.65% | ↗ |
| 139 | 2010 | Judith E. O’Grady Senior Vice President, Regulatory Affairs and Quality Systems, and Corporate Compliance Officer | 248.7K | — | 58.7K | — | 63.8K | 3.9K | 375.0K | 15.65% | ↗ |
| 140 | 2010 | Jerry E. Corbin Vice President, Corporate Controller and Principal Accounting Officer | 245.6K | — | 61.0K | — | 63.8K | 4.1K | 374.5K | 16.29% | ↗ |
| 141 | 2010 | Jerry E. Corbin Vice President, Corporate Controller and Principal Accounting Officer | 245.6K | — | 61.0K | — | 63.8K | 4.1K | 374.5K | 16.29% | ↗ |
| 142 | 2009 | Stuart M. Essig Chief Executive Officer | 614.8K | — | 4.20M | — | — | 3.6K | 4.81M | 87.15% | ↗ |
| 143 | 2009 | Stuart M. Essig Executive Chairman and Former Chief Executive Officer | 614.8K | — | 4.20M | — | — | 3.6K | 4.81M | 87.15% | ↗ |
| 144 | 2009 | Stuart M. Essig President and Chief Executive Officer | 614.8K | — | — | — | — | — | 4.81M | 0.00% | ↗ |
| 145 | 2009 | John B. Henneman, III Executive Vice President, Finance and Administration, and Chief Financial Officer | 457.4K | — | 417.5K | — | — | 3.6K | 878.6K | 47.52% | ↗ |
| 146 | 2009 | John B. Henneman, III Executive Vice President, Finance and Administration, and Chief Financial Officer | 457.4K | — | 417.5K | — | — | 3.6K | 878.6K | 47.52% | ↗ |
| 147 | 2009 | Gerard S. Carlozzi Former Executive Vice President and Chief Operating Officer | 457.4K | — | 180.0K | — | — | — | 637.4K | 28.24% | ↗ |
| 148 | 2009 | Gerard S. Carlozzi Executive Vice President and Chief Operating Officer | 457.4K | — | — | — | — | — | 637.4K | 0.00% | ↗ |
| 149 | 2009 | Judith E. O’Grady Senior Vice President, Regulatory Affairs, Quality Assurance and Clinical Affairs, and Corporate Compliance Officer | 244.4K | — | — | — | — | — | 482.7K | 0.00% | ↗ |
| 150 | 2009 | Judith E. O’Grady Senior Vice President, Regulatory Affairs and Quality Systems, and Corporate Compliance Officer | 244.4K | — | 146.7K | — | 88.0K | 3.6K | 482.7K | 30.38% | ↗ |
| 151 | 2009 | Judith E. O’Grady Senior Vice President, Regulatory Affairs and Quality Systems, and Corporate Compliance Officer | 244.4K | — | 146.7K | — | 88.0K | 3.6K | 482.7K | 30.38% | ↗ |
| 152 | 2009 | Jerry E. Corbin Vice President, Corporate Controller and Principal Accounting Officer | 231.0K | — | 150.2K | — | 91.5K | 3.6K | 476.3K | 31.53% | ↗ |
| 153 | 2009 | Jerry E. Corbin Vice President, Corporate Controller and Principal Accounting Officer | 231.0K | — | 150.2K | — | 91.5K | 3.6K | 476.3K | 31.53% | ↗ |
| 154 | 2009 | Peter J. Arduini President and Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
| 155 | 2009 | Peter Arduini President and Chief Operating Officer | — | — | — | — | — | — | — | — | ↗ |
| 156 | 2008 | Stuart M. Essig Chief Executive Officer | 600.0K | — | 21.54M | — | — | 3.9K | 24.50M | 87.91% | ↗ |
| 157 | 2008 | Stuart M. Essig President and Chief Executive Officer | 600.0K | — | — | — | — | — | 24.50M | 0.00% | ↗ |
| 158 | 2008 | John B. Henneman, III Executive Vice President, Finance and Administration, and Chief Financial Officer | 444.8K | — | 3.35M | — | — | 3.9K | 4.67M | 71.74% | ↗ |
| 159 | 2008 | Gerard S. Carlozzi Former Executive Vice President and Chief Operating Officer | 444.8K | — | 3.35M | — | — | — | 3.79M | 88.27% | ↗ |
| 160 | 2008 | Gerard S. Carlozzi Executive Vice President and Chief Operating Officer | 444.8K | — | — | — | — | — | 3.79M | 0.00% | ↗ |
| 161 | 2008 | Judith E. O’Grady Senior Vice President, Regulatory Affairs, Quality Assurance and Clinical Affairs, and Corporate Compliance Officer | 242.8K | — | — | — | — | — | 346.7K | 0.00% | ↗ |
| 162 | 2008 | Judith E. O’Grady Senior Vice President, Regulatory Affairs and Quality Systems, and Corporate Compliance Officer | 242.8K | — | 100.0K | — | — | 3.9K | 346.7K | 28.85% | ↗ |
| 163 | 2008 | Jerry E. Corbin Vice President, Corporate Controller and Principal Accounting Officer | 227.4K | — | 100.0K | — | — | 3.9K | 331.3K | 30.19% | ↗ |
| 164 | 2008 | Jerry E. Corbin Vice President and Corporate Controller | 227.4K | — | 82.0K | — | — | 3.9K | 313.3K | 26.19% | ↗ |
| 165 | 2008 | Peter Arduini President and Chief Operating Officer | — | — | — | — | — | — | — | — | ↗ |
| 166 | 2007 | Stuart M. Essig President and Chief Executive Officer | 550.0K | — | — | — | — | — | 4.47M | 0.00% | ↗ |
| 167 | 2007 | John B. Henneman, III Executive Vice President, Finance and Administration, and Chief Financial Officer | 420.0K | — | — | — | — | — | 791.9K | 0.00% | ↗ |
| 168 | 2007 | Gerard S. Carlozzi Executive Vice President and Chief Operating Officer | 416.5K | — | — | — | — | — | 784.5K | 0.00% | ↗ |
| 169 | 2007 | Judith E. O’Grady Senior Vice President, Regulatory, Quality Assurance and Clinical Affairs | 234.1K | — | 87.3K | — | 69.6K | 3.9K | 550.0K | 15.87% | ↗ |
| 170 | 2007 | Judith E. O’Grady Senior Vice President, Regulatory Affairs, Quality Assurance and Clinical Affairs, and Corporate Compliance Officer | 234.1K | — | — | — | — | — | 473.1K | 0.00% | ↗ |
| 171 | 2007 | Maureen B. Bellantoni Former Executive Vice President and Chief Financial Officer | 220.7K | — | — | — | — | 349.2K | 452.8K | 0.00% | ↗ |
| 172 | 2007 | Jerry E. Corbin Vice President, Corporate Controller and Principal Accounting Officer | 207.1K | — | — | — | — | — | 383.5K | 0.00% | ↗ |
| 173 | 2007 | Jerry E. Corbin Vice President and Corporate Controller | 207.1K | — | 48.4K | — | 51.8K | 3.9K | 311.2K | 15.55% | ↗ |
| 174 | 2006 | Stuart M. Essig President and Chief Executive Officer | 500.0K | 500.0K | — | — | — | 3.8K | 3.53M | 0.00% | ↗ |
| 175 | 2006 | Stuart M. Essig President and Chief Executive Officer | 500.0K | — | — | — | 500.0K | 3.8K | 3.53M | 0.00% | ↗ |
| 176 | 2006 | Gerard S. Carlozzi Executive Vice President and Chief Operating Officer | 400.0K | 160.0K | 1.17M | — | — | — | 2.70M | 43.26% | ↗ |
| 177 | 2006 | Gerard S. Carlozzi Executive Vice President and Chief Operating Officer | 400.0K | — | 1.17M | — | 160.0K | — | 2.70M | 43.26% | ↗ |
| 178 | 2006 | John B. Henneman, III Executive Vice President, Finance and Administration, and Chief Financial Officer | 420.0K | 168.0K | 1.17M | — | — | 3.8K | 2.55M | 45.91% | ↗ |
| 179 | 2006 | John B. Henneman, III Executive Vice President, Finance and Administration, and Chief Financial Officer | 420.0K | — | 1.17M | — | 168.0K | 3.8K | 2.55M | 45.91% | ↗ |
| 180 | 2006 | David B. Holtz | 250.0K | — | 233.3K | — | — | 350.8K | 1.02M | 22.96% | ↗ |
| 181 | 2006 | Maureen B. Bellantoni Former Executive Vice President and Chief Financial Officer | 293.1K | — | 117.1K | — | 120.0K | 118.4K | 648.6K | 18.05% | ↗ |
| 182 | 2006 | Maureen B. Bellantoni Former Executive Vice President and Chief Financial Officer | 293.1K | 120.0K | 117.1K | — | — | 118.4K | 648.6K | 18.05% | ↗ |
| 183 | 2006 | Judith E. O’Grady Senior Vice President, Regulatory, Quality Assurance and Clinical Affairs | 227.6K | 3.0K | 37.4K | — | 41.1K | 3.8K | 480.7K | 7.78% | ↗ |
| 184 | 2006 | Judith E. O’Grady Senior Vice President, Regulatory Affairs, Quality Assurance and Clinical Affairs, and Corporate Compliance Officer | 227.6K | — | 37.4K | — | 44.1K | 3.8K | 480.7K | 7.78% | ↗ |
| 185 | 2006 | Judith E. O’Grady Senior Vice President, Regulatory, Quality Assurance and Clinical Affairs | 227.6K | — | 37.4K | — | 44.1K | 3.8K | 480.7K | 7.78% | ↗ |
| 186 | 2006 | Jerry E. Corbin Vice President and Corporate Controller | 97.2K | — | 6.3K | — | 32.2K | 1.8K | 137.6K | 4.59% | ↗ |
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Mojdeh Poul | President, Chief Executive Officer & Director | 2M | female |
| Michael J. McBreen | Executive Vice President & President of Codman Specialty Surgical | 942.9K | male |
| Lea Daniels Knight | Executive Vice President & Chief Financial Officer | 884.7K | female |
| Robert T. Davis Jr. | Executive Vice President & President of Tissue Technologies | 722.4K | male |
| Harvinder Singh | Executive Vice President & President of International Business | 714.6K | male |
| Michael D. Hutchinson | Executive Vice President, Chief Legal Officer & Secretary | 549.5K | male |
| Jeffrey Mosebrook | Senior Vice President of Finance & Principal Accounting Officer | 493.1K | male |
| Teshtar Elavia | Corporate VP & Chief Technology Officer | — | male |
| Laurene Isip | Vice President of Global Corporate Communications & Public Relations | — | — |
| Christopher Ward | Senior Director of Investor Relations | — | — |
| Transaction Date | Disclosed | Senator | State | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2015-02-13 | 2015-02-26 | Thom Tillis | NC | Joint | Sale (Full) | $1,001 - $15,000 | ↗ |
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2024-06-18 | 2024-07-09 | Josh Gottheimer | NJ05 | Joint | Sale | $1,001 - $15,000 | ↗ |
| 2024-04-05 | 2024-05-15 | Josh Gottheimer | NJ05 | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2023-10-16 | 2023-11-11 | Josh Gottheimer | NJ05 | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2023-09-15 | 2023-10-15 | Josh Gottheimer | NJ05 | Joint | Sale | $1,001 - $15,000 | ↗ |
| 2023-06-13 | 2023-07-11 | Josh Gottheimer | NJ05 | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2020-10-16 | 2020-11-05 | Josh Gottheimer | NJ05 | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2020-09-15 | 2020-10-13 | Josh Gottheimer | NJ05 | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2020-03-10 | 2020-04-16 | Gilbert Cisneros | CA31 | -- | Purchase | $1,001 - $15,000 | ↗ |
| 2020-02-10 | 2020-03-10 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2020-02-03 | 2020-03-16 | Josh Gottheimer | NJ05 | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2019-01-09 | 2020-04-27 | Donna Shalala | FL27 | -- | Sale (Full) | $1,001 - $15,000 | ↗ |
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for IART
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
